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ABSTRACT OF THESIS 
 
 
 
 
DISCRIMINATING BETWEEN ADHD,  
ADHD WITH A COMORBID PSYCHOLOGICAL DISORDER AND  
MALINGERED ADHD IN A COLLEGE SAMPLE 
 
 
 The current study examined the efficacy of various neuropsychological measures 
for differentiating ADHD and comorbid ADHD from malingered ADHD in a large state 
university sample. The sample consisted of 23 nonclinical individuals assigned to 
malinger ADHD (NLM), 9 nonclinical individuals responding honestly (NLH), 22 
individuals with diagnoses of ADHD only (ADHD-H), 9 individuals with comorbid 
ADHD/Learning Disorder presentations (ADHD-LD), and 13 individuals with comorbid 
ADHD/Anxiety presentations (ADHD-ANX). Due to limited sample sizes, the ADHD-
LD and ADHD-ANX participants were pooled to create a comorbid ADHD group 
(ADHD-CO n = 22). The study utilized a simulation design with a NLM group instructed 
to feign ADHD while the other groups responded under standard instructions. The 
TOMM, LMT, NV-MSVT, and CTIP variables performed well, but the DMT did not. 
The WAIS-IV and WJ-III variables did not adequately differentiate malingered and 
comorbid ADHD.  
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Chapter 1: Introduction 
Attention Deficit/Hyperactivity Disorder 
 Attention Deficit/Hyperactivity Disorder (ADHD) is an Axis I psychological 
disorder characterized by inattentive or hyperactive-impulsive symptoms which persist 
for a period of at least six months. According to the Diagnostic and Statistical Manual of 
Mental Disorders-IV (DSM-IV) criteria, impairment must be present in multiple settings 
with an initial onset before age seven and must be more extreme than what individuals 
might experience in their normal developmental course (APA, 2000). ADHD has three 
subtypes: inattentive, hyperactive, and combined. ADHD, Predominantly Inattentive 
Type is diagnosed when an individual displays six or more inattentive symptoms, such as 
distractibility, careless mistakes, forgetfulness, difficulty organizing, problems sustaining 
attention, etc. ADHD, Predominately Hyperactive-Impulsive Type may be diagnosed 
when an individual exhibits six or more symptoms of either hyperactivity or impulsivity 
(APA, 2000). Relevant symptoms include excessive talking, difficulty waiting one’s turn, 
fidgeting, leaving one’s seat at inappropriate times, frequent interrupting, trouble playing 
quietly, etc. ADHD, Predominantly Combined Type may be diagnosed when six or more 
symptoms from both the inattentive and hyperactive-impulsive categories are present. 
ADHD, Not Otherwise Specified (NOS) may be diagnosed when criteria are met but 
symptoms were not present before age seven or when significant impairment is present 
but not all criteria are met (APA, 2000). A primary difficulty in developing accurate 
diagnoses in cases of adult ADHD is establishing and verifying that symptoms were 
present before age seven.  
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 Rates of diagnosed adult ADHD have increased dramatically over the past two 
decades, likely in response to the growing awareness that the ADHD phenomenon is not 
confined to childhood but often persists well into adulthood (Quinn, 2003). The DSM-IV 
(APA, 2000) estimated that the prevalence of ADHD in school-age children ranges from 
three to seven percent; however, data for prevalence in adulthood was limited at the time 
of publication. The newest manual, the DSM-5 (APA, 2013), estimates that 
approximately 2.5% of the general adult population may have ADHD, though 
information is still limited. Both accurate diagnosis and accurate prevalence estimates are 
complicated by the DSM-IV diagnostic criterion requiring that symptoms be present 
before the age of seven because adults may have trouble recalling childhood impairment 
and judging whether it was more extreme or distressing than what their peers may have 
experienced. 
Malingering and ADHD  
 Quinn (2003) suggested that malingering may be part of the reason why adult 
ADHD is so difficult to diagnose. Malingering has been defined by the DSM-IV-TR as 
“the intentional production of false or grossly exaggerated physical or psychological 
symptoms, motivated by external incentives” (APA, 2000, p. 739). Base rates of 
malingering are difficult to obtain since malingerers rarely confess, but it is logical to 
assume that the prevalence of malingering would vary, at least in part, in accordance with 
the context of the assessment. In other words, base rates of malingering are assumed to be 
higher in the context of litigation or compensation seeking than what one would expect to 
find in an employment setting or child custody case. Malingering of ADHD is now 
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recognized as a widespread problem, particularly in cases where there is potential for 
secondary gain (Harrison, 2006).  
 Among young adults, particularly in a college setting, there is an array of 
incentives, or potential benefits an individual may receive upon successfully malingering 
ADHD. Possible incentives include academic accommodations, performance-enhancing 
drug effects, and recreational use of stimulant medication (Harrison, 2006; Kane, 2008; 
McCabe, Knight, Teter, & Wechsler, 2005). The transition from high school into college 
can be a difficult time for young adults due to the increased workload, responsibility, and 
competition (Kane, 2008). College students likely feel external pressure secondary to the 
increased demands placed upon them and a heightened fear of failure. These individuals 
may observe that friends or other students seem to have an easier time completing 
assignments and tests because of special accommodations they receive for their ADHD 
diagnosis, such as extra time on tests and assignments, separate and individual testing, 
access to instructor notes, lighter workloads, financial aid, and use of electronic aids 
(Harrison, 2006). The individual may discern the advantages to successfully faking 
ADHD and schedule a consultation with the on-campus clinic or a primary care physician 
in pursuit of accommodations.  
 Similarly, individuals may be motivated to fake ADHD to receive a prescription 
for stimulant medications (Quinn, 2003; Sullivan, May, & Galbally, 2007). It is not 
uncommon for individuals to purchase or otherwise obtain prescription medications from 
an acquaintance during the more stressful times of the semester. McCabe et al. (2005) 
estimated that as many as 7% of college students surveyed had used prescription 
stimulant medications for non-medical purposes at some point. If this behavior is 
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reinforced with enhanced cognitive focus and increased ability to stay awake, the 
individual may decide it would be beneficial to receive a personal prescription to 
maximize school performance. 
  Another external motivation for attempting to malinger an ADHD diagnosis is 
even more concerning. Individuals may fake ADHD to acquire stimulant medications for 
recreational use (Conti, 2004). A study by Quintero (2009) stated that poly-drug use 
involving pharmaceuticals and including stimulants was reported for an alarming 90% of 
the college population studied. In 2000, Babcock and Byrne found that as many as 16% 
of students at a public, liberal arts university admitted to recreational use of 
methylphenidate, and Booksh, Pella, Singh, and Gouvier (2010) noted that current 
stimulant abuse rates appear to be even higher than they were 10 years ago. Stimulant 
medications may be inhaled or injected, and it has also become fairly common for 
individuals to mix different drugs together to intensify their effects, often combining 
stimulant medications with alcohol and other psychoactive substances to prolong feelings 
of euphoria (Harrison, 2006). This practice has some very obvious and serious risks. 
Thus, it has grown increasingly important to identify objective ways of detecting 
malingering in ADHD evaluations at both the local campus and wider community levels 
to prevent the unjust acquisition and dangerous misuse of prescription stimulant 
medications. 
 Research on malingered ADHD. 
 The research that has been conducted on malingered ADHD up to this point 
illustrates the ease of feigning ADHD, especially considering that measures of motivation 
and effort are not usually included in ADHD evaluations. Because ADHD is typically 
 
5 
diagnosed with self-report measures, it is relatively easy for individuals to endorse 
symptoms that they do not actually have, and very few self-report scales are equipped 
with validity checks to detect feigning (Harrison, 2006; Quinn, 2003). In this 
technological age, individuals motivated to feign ADHD can also find an abundance of 
information on the internet, inclusive of medical and diagnostic criteria. As a result of the 
accessibility of diagnostically relevant information and the lack of validity scales in most 
self-report tests, these measures are unable to differentiate true ADHD from feigned 
ADHD and should not be the sole means of evaluation in ADHD assessment (Fisher & 
Watkins, 2008; Quinn, 2003).  
 The importance of understanding and detecting malingering has only recently 
been recognized by researchers in the field of clinical psychology, and research up to this 
point has primarily focused on malingering in areas such as mild traumatic brain injury 
(mTBI). The study of malingered ADHD is still in the developmental phase, with the 
majority of studies on this topic having been published in the last 15 years. Several of the 
published studies have utilized the differential prevalence design in the context of an 
ADHD evaluation. In differential prevalence designs, the researcher is assuming that two 
different groups of individuals (e.g. compensation seeking versus non-compensation 
seeking) will have different base rates of malingering, and the assumption is usually 
based on potential for external gain or perceived incentives (Rogers, 2008).  
 In one such archival study, Marshall, Schroeder, O’Brien, Fischer, Ries, Blesi, et 
al. (2010) classified individuals as exhibiting suspect or credible effort based on their 
performance on various symptom validity tests. The symptom validity test (SVT) is a 
widely accepted strategy utilized in the detection of malingering. Most SVTs typically 
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employ a two-item, forced-choice paradigm where the target stimulus is initially 
presented, and after a short delay, the target stimulus is presented again alongside a 
second stimulus (Willison & Tombaugh, 2006). The task for the participant is to 
recognize the original target stimulus and select it from among the two choices. SVTs 
have been the driving force in malingering test development and research up to this point 
because they have demonstrated high sensitivity to malingering (Willison & Tombaugh, 
2006).  
 Marshall et al. (2010) examined the effectiveness of various SVTs in identifying 
symptom exaggeration. All participants completed the same core test battery in a referral 
for ADHD evaluation, and they were classified as exhibiting suspect effort if they either: 
failed two SVTs, failed one SVT and gave an unusually impaired performance on a 
cognitive test, or if they failed a single SVT or appeared unusually impaired on a 
cognitive test and had invalid completion of behavior rating scales (Marshall et al., 2010). 
Four groups were defined and compared retrospectively: ADHD credible, non-ADHD 
credible, ADHD suspect, and non-ADHD suspect. The results of the study revealed 
sensitivity to suspect test-taking effort ranging from 47% to 64% for the b Test e score, 
the Test of Variable Attention (TOVA) reaction time variability, the Conners’ CPT-II 
omission errors, the TOVA omission errors, and the Word Memory Test (WMT) 
consistency and immediate recall scores, in ascending order (Marshall et al., 2010).  
 Other studies utilizing differential prevalence designs have classified sub-optimal 
effort or non-credible performance based solely on failure of the WMT (Sullivan et al., 
2007; Suhr, Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008). Sullivan et al. 
(2007) utilized this design in the context of both ADHD and LD evaluations and found 
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that 47.6% of individuals exhibited suboptimal effort based on this criterion. Analyses of 
ADHD only individuals revealed that the suboptimal effort group produced significantly 
worse scores on the Immediate Recognition, Short-Delay Recall, and Long-Delay Recall 
trials of the CVLT-2. The suboptimal effort group was also found to produce higher 
CAARS scores (Sullivan et al., 2007). 
 Suhr et al. (2008) compared a non-credible performance group with an ADHD 
group and a psychological symptoms control group on neuropsychological test 
performance. Their results showed that the non-credible group performed significantly 
worse than both clinical control groups on all trials of the Auditory Verbal Learning Test 
(AVLT), the WAIS-III Working Memory Index, and the Trail Making Test Part B. Both 
the non-credible group and ADHD controls performed significantly worse than the 
psychological symptoms controls on the Stroop Color Word Interference t score (Suhr et 
al., 2008). A more recent study by Suhr, Sullivan, and Rodriguez (2011) extended the 
findings of the former study, using a subset of the original sample, to examine Conner’s 
Continuous Performance Test (CPT). The non-credible group performed significantly 
worse than psychological symptoms controls on many CPT scores, including omissions, 
commissions, reaction time, discriminability, reaction time variability, and reaction time 
change over interstimulus intervals, but was only differentiated from the ADHD control 
group by the latter two variables (Suhr et al., 2011).  
 Other studies have utilized a simulation design where the malingering groups are 
constructed in analogue research (Rogers, 2008). In this design, participants are typically 
given a scenario describing a hypothetical situation in which they would receive external 
benefits if they were to successfully malinger deficits. Monetary incentives are 
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commonly offered to the participants to enhance their motivation to fake well, and test 
performances of the individuals instructed to malinger can then be compared with clinical 
or normal controls, depending on the purpose of the study (Rogers, 2008).  
 One of the first published studies to utilize a simulation design for examining 
malingering in the context of ADHD compared the performance of controls, simulated 
malingerers, and ADHD participants on the Integrated Visual and Auditory Continuous 
Performance Test (IVA CPT) and the ADHD Behavior Checklist (Quinn, 2003). Quinn 
found that the ADHD Behavior Checklist was successfully faked with no significant 
differences between the ADHD participants and simulators. However, 81% of the scales 
on the IVA CPT could not be faked, and the CPT exhibited 94% sensitivity to 
malingering with specificity of 91% (Quinn, 2003). Fisher and Watkins (2008) found 
further evidence that individuals can fake self-report scales with relative ease. Of the 189 
individuals with no significant history of ADHD instructed to simulate in their study, 
93% of those who completed the College ADHD Response Evaluation (CARE) and 77% 
of those who completed the ADHD Behavior Checklist successfully faked the scales after 
studying ADHD diagnostic criteria for only five minutes (Fisher & Watkins, 2008).  
 Another simulation study by (Booksh et al., 2010) compared ADHD simulators 
with ADHD controls and normal controls on objective measures of attention. They found 
that the simulation group performed significantly worse than the ADHD control group on 
half of the objective measures utilized, including the TMT Part A, CPT mean t scores, 
and the sum of CPT elevation (Booksh et al., 2010). In 2008, Frazier, Frazier, Busch, 
Kerwood, and Demaree investigated the ability of SVTs, including the Victoria Symptom 
Validity Test (VSVT) and the Validity Indicator Profile (VIP), to distinguish normal 
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undergraduate participants from those instructed to simulate ADHD and reading disorder 
(RD). They found that at varying cut scores, these two measures were able to differentiate 
simulated ADHD and RD from normal controls with sensitivity rates generally above 
80% and higher for RD than ADHD (Frazier et al., 2008). However, this study provided 
no comparison with clinical controls.   
 A 2007 study by Harrison, Edwards, and Parker compared test performance of 
ADHD simulators with both normal and ADHD controls. The non-ADHD participants in 
their study included 70 undergraduate students. Data from these participants were 
compared with archival data from 72 ADHD cases. All participants in the study 
completed the Conners’ Adult ADHD Rating Scale (CAARS) and subtests from the 
Woodcock Johnson Psychoeducational Battery-III (WJPB-III), specifically the Reading 
Fluency and Processing Speed subtests (Harrison et al., 2007). Using the recommended 
cut score for the CAARS, most participants in the “faking” group were able to 
successfully meet the criteria for a diagnosis of ADHD, but they trended toward higher 
scores than that of the ADHD group. Additionally, individuals in the “faking” group 
performed significantly worse on WJPB-III subtests using a liberal cut score (Harrison et 
al., 2007). From their results, the authors suggest that exaggerated high scores on self-
report CAARS items may be used in conjunction with unlikely low scores on WJPB-III 
and similar standardized tests to help identify individuals feigning ADHD (Harrison et 
al., 2007).  
 Two recent studies have utilized more comprehensive and extensive test batteries 
with a combination of embedded indices from classic neuropsychological tests and 
symptom validity tests to compare test performance of simulated malingerers with a 
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variety of control groups in a college population (Sollman, Ranseen, & Berry, 2010; 
Jasinski, Harp, Berry, Shandera-Ochsner, Mason, & Ranseen, 2011). Sollman et al.’s 
study (2010) compared ADHD simulators with ADHD controls and normal controls on a 
wide array of measures, including self-report scales, neuropsychological measures, and 
feigning and symptom validity tests. Self-report scales included the ADHD rating scale 
(ARS) and the Conners’ Adult ADHD Rating Scale (CAARS). Neuropsychological 
measures included the Conners’ Continuous Performance Test-II (C-CPT), the Stroop 
Color-Word Test, the Wechsler Memory Scale Word Lists subtest (WMS-WL), and the 
Nelson-Denney Word Reading Test (NDWR). Malingering instruments included the 
Miller Forensic Assessment of Symptoms Test (M-FAST), a psychiatric feigning 
measure, and symptom validity tests such as the Digit Memory Test (DMT), the Letter 
Memory Test (LMT), the Test of Memory Malingering (TOMM), and the Nonverbal-
Medical Symptom Validity Test (NV-MSVT).  
 Sollman et al. (2010) found that both self-report scales were highly sensitive to 
ADHD, but were unable to differentiate honest ADHD from malingerers. Comparisons 
across neuropsychological measures revealed that feigners performed significantly worse 
than ADHD controls on the Stroop Word and Color mean scores and on contrast 2 of the 
WMS (Sollman et al., 2010). Evaluation of the C-CPT found this measure insensitive to 
ADHD in the sample, though the feigning group was able to generate typical ADHD 
profiles. Analysis of the SVTs utilized in the study revealed that the TOMM, DMT, 
LMT, and NV-MSVT all exhibited at least moderate sensitivity to feigning and good 
specificity, with robust effect sizes ranging from -.96 and -.97 on the scales of the NV-
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MSVT to as high as -1.6 for Trial 1 percentage correct on the TOMM (Sollman et al., 
2010).  
 In an extension of Sollman et al.’s (2010) findings, Jasinski, Harp, et al. (2011) 
used a modified battery to compare the test performance of ADHD simulators with 
participants in various experimental conditions. The comparison groups for the study 
included an honest normal control group, an ADHD malingering group, an ADHD honest 
group, an ADHD exaggerate group, and a Mood disorder group. Participants completed 
the CAARS, the Reading fluency subtest of the Woodcock-Johnson Test of 
Achievement-III (WJ-III), the Coding, Symbol Search, and Digit Span subtests of the 
Wechsler Adult Intelligence Scale-IV (WAIS-IV), the Computerized Test of Information 
Processing (CTIP), and the following SVTs: the DMT, LMT, TOMM, NV-MSVT, and b 
Test (Jasinski, Harp, et al. 2011). The most significant results of this study were the 
robust findings surrounding the Symptom Validity Tests. The TOMM, DMT, LMT, and 
NV-MSVT differentiated the feigning group from the ADHD group by nearly one 
standard deviation. Effect sizes ranged from -1.01 to -1.24 with malingerers exhibiting 
significantly worse performance on all measures. The neuropsychological measures also 
yielded some interesting results. Many of the CTIP variables were able to discriminate 
feigning from ADHD with effect sizes ranging from .82 to 1.01 (Jasinski, Harp, et al., 
2011). The WAIS-IV PSI and Symbol Search subtest distinguished malingerers from 
honest responders as well as the SVTs, with the largest effect sizes of -1.47 and -1.52, 
respectively. Finally, the WJ-III also differentiated malingerers from honest ADHD 
individuals with effect sizes of -1.27 and -1.25 (Jasinski, Harp, et al., 2011). The latter 
two studies provide evidence for the combined utility of symptom validity tests and 
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neuropsychological measures in the evaluation of adult ADHD. Consideration of the 
results from the various studies on malingered ADHD should inform the measures 
selected for use in ADHD evaluations and increase recognition of which measures 
warrant further investigation in experimental settings.  
Comorbid ADHD 
 One area of the literature on feigned ADHD that is currently undeveloped is 
research on comorbid ADHD presentations. One study found that of the 335 adults 
interviewed who met criteria for ADHD, 49% also met criteria for another DSM-IV Axis 
I disorder (around 71% for lifetime Axis I comorbidity), and 50.7% also met criteria for 
an Axis II diagnosis (Cumyn, French, & Hechtman, 2009). Individuals with ADHD had a 
much higher likelihood of psychological symptoms than those without ADHD, and the 
most common comorbidities were anxiety and mood disorders (Cumyn et al., 2009). In 
their sample of 45 adult ADHD patients, Torgersen, Gjervan, and Rasmussen (2006) 
found that the lifetime prevalence of at least one comorbid disorder was 86.7%, with 
major depression greater than 50%, antisocial personality disorder approaching 50%, 
substance abuse around 50%, and learning disabilities in more than 20% of the sample. 
Sobanski (2006) asserts that of all patients with ADHD in adulthood, 65-89% suffer from 
at least one additional psychiatric disorder during their lifetime, with some of the highest 
lifetime comorbidity rates for anxiety disorders (40-60%). Thus, there is some 
consistency in the literature regarding high base rates for comorbidity in the adult ADHD 
population.  
 Miller, Nigg, and Faraone (2007) administered structured clinical interviews 
(SCID-I and II) to 152 adults with ADHD and 211 adult controls to determine Axis I and 
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Axis II comorbidity. For Axis I disorders, ADHD, Combined Type was significantly 
associated with the presence of externalizing disorders with 40.6% of the sample 
evidencing two or more externalizing disorders. ADHD, Combined and Inattentive types 
were similarly associated with internalizing disorders, with more than 30% of individuals 
warranting a diagnosis of at least one internalizing disorder (Miller et al., 2007). These 
percentages were significantly different from the control group. Furthermore, Miller et al. 
(2007) found that individuals with ADHD were also more likely to have Cluster B and C 
personality disorders (PD), with nearly half (47.4%) of the 18 individuals in the ADHD, 
Hyperactive group evidencing at least one Cluster B PD (Miller et al., 2007).  
 Epidemiological studies have indicated that when applying strict diagnostic 
criteria, ADHD and a Reading Disorder (RD) may be apparent in as many as 15% to 40% 
of individuals (APA, 2000; Rucklidge & Tannock, 2002). There is very little information 
available about how comorbid disorders may alter the appearance or presentation of 
ADHD and influence ADHD evaluations. Various comorbid disorders may enhance or 
even negate the symptoms of ADHD, or have little noticeable effect. Because such a 
significant portion of individuals with ADHD also have a second diagnosis, it is crucial 
to gain a better understanding of how comorbid diagnoses affect test performance, for the 
sake of ecological validity. Furthermore, it is essential to evaluate the utility of effort tests 
and neuropsychological embedded indices in discriminating between comorbid 
presentations and malingering.  
 The available research on how comorbid ADHD diagnoses affect performance on 
effort tests and neuropsychological tests is scarce. One study of adolescents with ADHD, 
RD, or comorbid ADHD + RD found differential deficits in test performance (Rucklidge 
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& Tannock, 2002). While the ADHD only group was slower at processing speed tasks 
(WISC-III coding and symbol search) and at naming colors and objects, the RD only 
group exhibited poorer verbal working memory and slower letter naming. Interestingly, 
the comorbid group exhibited cognitive deficits in addition to those of the ADHD group 
in areas such as overall reaction time, mental arithmetic, and working memory as 
measured by the WISC-III digits forward and backward (Rucklidge & Tannock, 2002).  
 As reviewed above, various scholarly articles have provided rather high estimates 
of comorbidity in the adult ADHD population, with some of the highest Axis I estimates 
for mood disorders, anxiety disorders, learning disorders, and substance abuse. However, 
no studies have yet examined whether the feigning measures which demonstrate strong 
sensitivity to feigned ADHD versus true ADHD can also differentiate feigned ADHD 
from ADHD with a second psychological disorder diagnosis that one might reasonably 
expect to complicate or impact test performance. 
Purpose of the Present Study 
 The present study used a simulation design and was conducted similarly to the 
recent study by Jasinski, Harp, et al. (2011) with a few methodological changes. One 
significant difference between the studies was the groups under consideration. 
Comparable to the previous study, the present study examined differences between non-
clinical individuals instructed to feign ADHD (NLM) and honest ADHD (ADHD-H) 
individuals. However, this study did not include an exaggerate ADHD group and only 
utilized a very small number of non-clinical controls as a manipulation check because the 
present study’s primary focus was to increase understanding of the differences between 
NLM, ADHD-H, and individuals with ADHD and other psychological diagnoses. 
 
15 
Therefore, the current study added another clinical control group comprised of 
individuals with ADHD and a comorbid psychological disorder (ADHD-CO) instead of 
the MOOD group utilized in the previous study. The ADHD-CO group was derived from 
combining two initially separate comorbid groups: an ADHD and Anxiety Disorder 
comorbid group and an ADHD and Learning Disorder comorbid group. It was felt that 
examining the discriminant ability of various instruments in the context of ADHD, 
comorbid ADHD, and malingered ADHD was the next step to understanding differences 
in test performance in ADHD assessments. There were also several modifications to the 
pre-test measures and test battery, such as the addition of the Wide Range Achievement 
Test, which was geared towards gathering more information about the ADHD-CO group.   
 The hypotheses of the study included the following: 1) the NLM (normal 
individuals responding under malingering instructions) group would perform 
significantly worse on measures of neurocognitive feigning as well as cognitive ability 
tests affected by attention processes than the ADHD-H (individuals with ADHD 
responding under standard instructions) group and ADHD-CO (individuals with 
comorbid ADHD/LD or ANX responding under standard instructions) group and would 
self-report significantly more ADHD related symptoms; 2) the ADHD-CO group would 
perform similarly to the ADHD-H group on neurocognitive feigning measures and self-
reported ADHD symptoms, but pretest screening and achievement measures would likely 
differentiate the two groups; and 3) the Digit Memory Test (DMT), the Letter Memory 
Test (LMT), the Test of Memory Malingering (TOMM), and the Nonverbal Medical 
Symptom Validity Test (NV-MSVT) would demonstrate the best sensitivity to feigning 
with high specificity for ADHD. 
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Chapter 2: Method 
Participants 
 The 76 participants in this study were undergraduate students at the University of 
Kentucky. The sample included 32 nonclinical participants and 44 participants with a 
diagnosis of ADHD. An ADHD screening form was included in the undergraduate mass 
screening session (PSY 100 subject pool) for the purpose of identifying and recruiting 
ADHD and non-ADHD individuals (see Appendix A). Participants from the subject pool 
were compensated with 5 of their required 6 research credits. The majority of participants 
were recruited via this route, though several individuals responded to fliers (see 
Appendix B) posted in the Disability Resource Center and were compensated with $40 
for their time.  
 The first subsample included 32 nonclinical individuals who were recruited from 
the psychology subject pool. In order to be selected for this group, the participants could 
not have a history of diagnosed or suspected ADHD, learning disorders, brain injury, 
neurological disorders, or psychiatric disorders. Nine of the nonclinical participants were 
randomly assigned to respond under standard instructions as a manipulation check for the 
assessment protocol (NLH) and 23 were randomly assigned to the malingering group 
(NLM).  
 The second subsample of participants included 22 individuals with ADHD 
diagnoses (ADHD-H). To be included in this group, individuals had to have a verifiable 
ADHD diagnosis before the age of 18, though this stricture was amended to “by age 12” 
part way through the study. A phone interview was used to establish that these diagnoses 
were received from or verified by a mental health practitioner and were not based solely 
 
17 
on either self-reported symptoms and/or a brief consultation. These individuals also could 
not have a history of brain injury, neurological disorders, or psychiatric disorders.  
 The third subsample of participants consisted of 9 individuals with verifiable 
comorbid ADHD and Learning Disability diagnoses (ADHD-LD). The ADHD-LD group 
included individuals with diagnosed reading and writing learning disabilities, because 
these learning disabilities most commonly co-occur with ADHD and are more apparent 
than math LD in the college population. Individuals with a history of brain injury, 
neurological disorders, or psychiatric disorders were excluded. A history of depression 
was not considered grounds for exclusion from this group given the high rates of 
comorbidity with ADHD and LD and the relatively low base rate of comorbid ADHD 
and LD in the college population. To be included in this group, individuals had to have an 
LD diagnosis based on more than self-report or a brief consultation. The same diagnostic 
restrictions which applied to the ADHD only group applied to this group as well, except 
the ADHD diagnostic age was not amended to “by age 12.”  
 The final subsample of participants consisted of 13 individuals with verifiable 
comorbid ADHD and an anxiety disorder (ADHD-ANX). Individuals in this group had to 
have verifiable ADHD and Anxiety diagnoses, based on more than a brief consult and/or 
self-report. Exclusion criteria for this group included a history of learning disabilities, 
brain injury, neurological disorder, and other psychiatric disorders, excepting a history of 
depression. The same diagnostic restrictions which applied to the ADHD-H and ADHD-
LD groups were used with this group as well.  
 Due to small sample sizes in the latter two groups, they were combined to form a 
comorbid ADHD group (ADHD-CO n = 22). Demographic characteristics of the sample 
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(age, gender, race, etc.) approximated the larger undergraduate population, with the 
exception of race which was much less heterogeneous in the sample. Individuals below 
the age of 18 were not included in the study. Individuals currently being treated for 
ADHD were asked to refrain from use of stimulant medications for 12 hours prior to 
testing.  
Design 
 The study utilized a simulation design. The 32 individuals recruited with no 
diagnosed psychopathology were be randomly assigned to two groups. A group of 9 
individuals were instructed to respond honestly, giving their best effort throughout the 
test battery. This small group functioned as a manipulation check for the assessment 
protocol. The remaining 23 individuals comprised the NLM group. Participants in this 
group were given a scenario (see Appendix I) describing a situation where it would be to 
their benefit to successfully fake ADHD and receive a diagnosis based on their test 
results. They were then presented with information on common symptoms and 
presentations of ADHD (see Appendix J), easily accessible via the internet. Once the 
participants had adequate time to look over the symptom list, they were instructed to 
respond to all test measures as if they are attempting to receive a diagnosis of ADHD, 
without creating an obvious faking presentation. Participants in this group were offered a 
“conditional” incentive of $25 if they successfully simulated ADHD without being 
detected by the tests. In reality, all participants in the feigning group received this 
monetary compensation during the debriefing session, as required by the Institutional 
Review Board. Both the honest ADHD and comorbid ADHD clinical groups were given 
standard instructions for completion of the test battery. This design was chosen to allow 
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the researcher to evaluate the hypotheses based on comparisons of group performance 
and to determine estimations of classification accuracy for each of the tests at various cut 
scores. This design also permitted the researcher to examine which measures, if any, best 
differentiate between the pure ADHD and comorbid ADHD groups.  
Assessment 
 Pre-test measures. 
The following pre-test materials were utilized in this study: an ADHD screening 
measure, a brief phone interview, informed consent forms, and a demographics 
questionnaire. The screening measure (see Appendix A) was included in the psychology 
subject pool/mass screening session to recruit participants. It asked students to indicate 
whether they had been diagnosed with ADHD, a Learning Disorder, an Anxiety Disorder 
or additional psychiatric or neurological disorders. The form also requested additional 
information about ADHD and other diagnoses (e.g. diagnostic age, medications, 
accommodations, etc.). The phone interview (see Appendices C, D, E, and F) was 
utilized to discern whether a given individual wished to participate in the study, whether 
that individual met the inclusion and exclusion criteria for the study, and which 
experimental condition was most appropriate given the individual’s psychiatric history. 
The informed consent form provided participants with information about the study, 
including risks and benefits of the study, and required the signature of the participant and 
researcher before resuming study procedures. The demographics questionnaire (see 
Appendix G) asked the participant to provide some personal information, including age, 
race, gender, etc. The questionnaire also asked individuals to indicate their psychiatric 
diagnoses and whether they were receiving treatment at the time of evaluation.  
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Pre-test measures administered to all participants included the Adult ADHD Self-
Report Scale (ASRS), the Beck Depression Inventory-II (BDI-II), the Beck Anxiety 
Inventory (BAI), and the Word Reading, Sentence Comprehension, and Spelling subtests 
of the Wide Range Achievement Test-IV (WRAT-4). All of the pre-test measures were 
administered under standard instructions before specific condition instructions were 
given. These instruments were utilized with the purpose of gathering more information 
about between group differences on pre-existing symptomatology. Given that Jasinski, 
Harp et al. (2011) found the highest base rates for these specific comorbidities 
(Depression, Learning Disorder, and Anxiety) in their preliminary sample, these 
measures were considered appropriate for gathering additional information about the 
participants with comorbid ADHD presentations recruited for this study.  
Adult ADHD Self-Report Scale (ASRS). The ASRS (Kessler, et al., 2005) is a 
brief instrument requiring about 5 minutes to complete. It inquires about 18 DSM-IV 
ADHD symptoms on Likert scales, and as a self-report measure for ADHD, the ASRS 
has demonstrated adequate sensitivity at 56.3% and strong specificity at 98.3%, with an 
overall hit rate of 96.2% (Kessler, et al., 2005).  
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown, 
1996) was used in the pre-test session to gather information about the current depression 
symptoms of participants. The BDI-II is a self-report scale requiring five to 10 minutes 
completion time. The instrument consists of 21 items designed to gauge current 
symptoms of depression (during the two weeks prior to examination). The responses are 
weighted, where 0 represents lack of symptoms and 4 represents severe symptomatology. 
The maximum score on the measure is a 63, and scores are classified in ranges from 
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minimal depression scores of 0-13 and mild scores of 14-19 to moderate scores of 20-28 
and severe scores of 29-63. The BDI-II has demonstrated fairly impressive (r = .93) test-
retest reliability (i.e. high correlation between test scores at Time 1 and Time 2), 
providing some evidence for construct validity of the instrument (Beck, et al., 1996). 
Beck Anxiety Inventory (BAI). The BAI (Beck & Steer, 1993) is similar to the 
BDI-II but was designed as a screening tool for symptoms of anxiety. The BAI is also a 
21-item self-report inventory requiring participants to endorse their experience of anxiety 
symptoms in the past week. The BAI also has a maximum score of 63. The descriptive 
categories are somewhat different from the BDI-II, however, with minimal anxiety scores 
of 0-7, mild scores of 8-15, moderate scores of 16-25, and severe scores of 26-63. The 
BAI has also demonstrated strong test-retest reliability, indicating that both of these 
screening instruments assess stable rather than highly variable symptoms (Beck & Steer, 
1993).  
 Wide Range Achievement Test-IV (WRAT-4). The WRAT-4 (Wilkinson & 
Robertson, 2006) is a widely used achievement test comprised of four subtests in word 
reading, sentence comprehension, spelling, and math computation, the first three of 
which were included in the present study. The word reading subtest requires individuals 
to recognize and name letters and pronounce words out of context. Sentence 
comprehension is a subtest novel to this edition which measures an individual’s ability to 
gather meaning from words and understand ideas presented in sentence form. Finally, the 
spelling subtest requires the test-taker to write letters and words spoken aloud by the 
examiner. The test is available in two alternate forms, and administration time for either 
form takes 15 to 45 minutes depending on the test-taking style and age of the examinee 
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(Wilkinson & Robertson, 2006). Past research (Rucklidge & Tannock, 2002) examined 
the performance of adolescents with ADHD, Reading Disorder, or comorbid ADHD and 
Reading Disorder on the Reading and Spelling subtests of the WRAT-3. In this study, 
normal controls and individuals with ADHD performed comparably on the Reading 
subtest, and the Reading Disorder group and comorbid ADHD and Reading Disorder 
group exhibited lower performances. On the Spelling subtest, normal controls performed 
better than individuals with ADHD, who in turn performed better than individuals with 
Reading Disorder and comorbid ADHD and Reading Disorder.   
 Test battery. 
 At the conclusion of the pre-test session, participants were given their individual 
packets with their instructions to complete the core test battery accordingly. The core test 
battery included a combination of self-report measures, symptom validity tests, and other 
neuropsychological measures thought to differentiate between honest responders and 
feigners. The battery was administered in counterbalanced order and included the 
following instruments: The Barkley Adult ADHD Rating Scale-IV (BAARS-IV), the 
Wechsler Test of Adult Reading (WTAR), the Digit Memory Test (DMT), the Letter 
Memory Test (LMT), the Nonverbal Medical Symptoms Validity Test (NV-MSVT), the 
b test, the Test of Memory Malingering (TOMM), the Computerized Test of Information 
Processing (CTIP), the Digit Span, Symbol Search, and Coding subtests of the Wechsler 
Adult Intelligence Scale-IV (WAIS-IV), and the Reading Fluency subtest of the 
Woodcock Johnson-III Tests of Achievement (WJ-III).  
 Barkley Adult ADHD Rating Scale-IV (BAARS-IV). The BAARS-IV (Barkley, 
2011) assesses current ADHD symptoms and recollections of childhood impairment with 
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both self-report and other-report forms based directly on the DSM-IV diagnostic criteria. 
The scale for current symptomatology was utilized in this study to gauge differences in 
self-reports between individuals completing the scale under malingering instruction 
versus those with genuine ADHD diagnoses. This scale includes an additional section 
targeting newly identified symptoms specifically relevant to ADHD, Inattentive Type. 
The long version of the scale takes approximately 5 to 7 minutes to complete. The scale 
has evidenced high internal consistency (α=.92) and high test-retest reliability (r=.75) for 
current ADHD symptoms and childhood symptoms scores, respectively (Barkley, 2011). 
 The BAARS-IV has Inattention, Hyperactivity, and Impulsivity indices, and the 
raw scores combine to produce a Total ADHD symptom index. An additional category, 
Sluggish Cognitive Tempo (SCT), is measured but not included in the overall ADHD 
score. Aside from these raw scores which provide an overall picture of symptom 
endorsement, the BAARS-IV also gauges symptom severity with a “Symptom Count” 
variable which measures the number of items to which an individual responds with either 
a “3” or a “4,” with “4” being the most often or most severe. Symptom counts are 
calculated for each of the aforementioned variables, with the Hyperactivity and 
Impulsivity indices combined to produce a single symptom count (Barkley, 2011). All of 
the aforementioned variables were examined in this study. 
 The Wechsler Test of Adult Reading (WTAR). The WTAR (Wechsler, 2001) is 
an instrument that is commonly used to obtain premorbid estimates of intelligence 
because it has shown resistance to neurologic injury and disorders. In light of the decision 
to administer the WRAT-4 Word Reading subtest under standard instruction during the 
pre-test session, the WTAR was given under experimental manipulation after individuals 
 
24 
received their condition instructions in order to gather information about how 
malingering instruction could potentially affect word reading scores. The WTAR requires 
individuals to read a list of atypically pronounced words aloud as the words become 
increasingly difficult, and the test administration time approximates 5-10 minutes 
(Wechsler, 2001).  
 Nonverbal Medical Symptom Validity Test (NV-MSVT). The NV-MSVT (Green, 
2008) is a computer-administered SVT that is theoretically similar to both the WMT and 
the MSVT where several subtests at different levels of difficulty measure memory and 
cognitive effort (Wager & Howe, 2010). The NV-MSVT uses a list of 10 pictures, each 
with a pair of items, which are presented across two trials. The participant must verbally 
name the parts of each picture aloud and then perform an immediate recognition task by 
choosing the correct picture of two options (Immediate Recall –IR). Following a 10 
minute delay, the participant completes a Delayed Recall (DR) task, similar in structure 
to the IR task. However, the DR task incorporates the more difficult DR-Archetypes and 
DR-Variations subtests into the same trial to enhance detection of diminished effort. The 
DR-A task involves pairing of a previously seen foil with a novel foil, and the DR-V 
involves pairing of the original target with a slightly modified picture. The test also 
involves a paired associations task where the individual is shown one part of an original 
picture and asked to identify what went with it and a free recall task where the individual 
is asked to name as many of the original items as possible from memory (Green, 2008; 
Wager & Howe, 2010). Much of the test is conducted by the computer in the absence of 
the examiner, and the computer generates feedback regarding accuracy of responses. The 
manual reports specificity estimates of 95% for dementia patients and 100% for control 
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groups. The manual also indicates that the NV-MSVT has a sensitivity rate in detecting 
poor effort of 72.5% (Green, 2008).  
 In a study comparing the NV-MSVT and the TOMM in outpatients undergoing 
disability assessment, Green (2011) found that twice as many individuals failed the NV-
MSVT as the TOMM. He attributed this finding to the NV-MSVT detecting more 
instances of poor effort given that the individuals with more abnormal brain scans were 
not typically the same individuals who failed the NV-MSVT. Furthermore, results 
showed that individuals detected as performing with suboptimal effort were likely to fail 
the easier subtests of the NV-MSVT while passing the more difficult tasks. He concluded 
that the NV-MSVT exhibits comparable, if not improved, sensitivity to feigning as that of 
the TOMM, and higher specificity to severe cognitive impairment (Green, 2011). Recent 
research suggests that the NV-MSVT has strong specificity (93%) but moderate 
sensitivity (47%) for detecting feigned versus genuine ADHD (Sollman et al., 2010). 
Jasinski, Harp, et al. (2011) found similar estimates, with specificity of 95% and 
sensitivity of 50%. More research is needed on this relatively new measure.  
Digit Memory Test (DMT). The DMT (Hiscock & Hiscock, 1989) is a widely 
used forced-choice measure which presents examinees with a five-digit stimulus, and 
then utilizes an immediate recall trial and a delayed recognition trial. The delay periods 
increase from 5 seconds up to 15 seconds to increase the perceived difficulty of the test. 
It is a face valid test of memory which is intentionally easy and relatively insensitive to 
brain damage. In a meta-analysis conducted by Vickery, Berry, Inman, Harris, and Orey 
(2001) the DMT performed better at discriminating between honest responders and 
dissimulators than the Dot Counting Test, the 15-Item Test, the 21-Item Test, and the 
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Portland Digit Recognition Test. The 32 studies included in the meta-analysis produced 
combined estimates of good to adequate sensitivity (89.7% to 71.3% for honestly 
responding clinical and normal individuals, respectively) for the DMT and excellent 
specificity (91.1% to 98.9%). The DMT has been studied in the detection of malingered 
ADHD, where it demonstrated 100% specificity and 43% sensitivity (Sollman, et al., 
2010). In Jasinski, Harp, et al. (2011), the DMT exhibited improved sensitivity of 50%, 
but somewhat diminished specificity of 95%.  
Letter Memory Test (LMT). The LMT (Inman, Vickery, Berry, Lamb, Edwards, 
and Smith, 1998) is comparable to the DMT, but it uses cards containing increasing 
numbers of letters. After a five-second delay, the participant is asked to recognize the 
letters they were shown from two, three, or four options of letter combinations. The nine-
trial, 45-item test was originally developed as a computer administered test, but was later 
adapted to a manual form (Schipper, Berry, Coen, & Clark, 2008). On both the LMT and 
DMT, errors in excess of a predetermined cut-off score suggest malingering of memory 
or attention impairment.  
A known-groups cross-validation of the LMT was conducted by Vagnini, 
Sollman, Berry, Granacher, Clark, Burton, et al. (2006) to determine how well the LMT 
was able to discriminate between individuals with TBI responding honestly and probable 
cognitive feigners. Their study revealed sensitivity of 64% and specificity of 98.4%. 
Cross-validation of the manual form of the LMT demonstrated sensitivity of 80% in 
differentiating probable cognitive feigning from an honest control group and specificity 
of 95% (Schipper et al., 2008). It has also demonstrated strong specificity (98%) and 
adequate sensitivity (76%) in detecting malingered neurocognitive dysfunction (Sollman 
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& Berry, 2011). A recent study examining the LMT in detection of malingered ADHD 
found very strong specificity (93%) and moderate sensitivity (52%) estimates (Sollman, 
et al., 2010). Furthermore, the study by Jasinski, Harp, et al. (2011) found slightly 
improved estimates using the recommended cutting score of <93 (SN=54.5, SP=96.4). 
Test of Memory Malingering (TOMM). The TOMM (Tombaugh, 1996) is 
another forced-choice measure which has been studied extensively in feigned traumatic 
brain injury samples and is widely used for the detection of malingering. The TOMM 
presents 50 line drawings in 3-second intervals across two learning trials. Participants are 
asked to recognize as many of the 50 drawings as they can when presented with two 
alternatives (one target, one foil). Following a 20-minute delay, participants complete a 
retention trial where they are again presented with 50 two-item alternatives and asked 
identify the original target item. The TOMM is a relatively simple task which can be 
completed successfully by people with severe TBI, and it is considered a strong tool for 
evaluations where malingering may be suspected (Vickery, et al., 2001). Rees, 
Tombaugh, and Boulay (2001) found that a 90% correct cutting score on the trials of the 
TOMM had high sensitivity and specificity for malingered memory deficits. Furthermore, 
a recent study (Sollman, et al., 2010) found that the TOMM performed adequately when 
detecting feigned ADHD, with strong specificity of 97% but reduced sensitivity of 47% 
at Trial 2. Jasinski, Harp, et al. (2011) found 90% specificity and 59.1% sensitivity for 
Trial 1 % Correct and 100% specificity and 45.5% sensitivity on Trial 2 % Correct and 
Retention % Correct. 
b Test. The b Test (Boone, Lu, Sherman, Palmer, Back, Shamieh, et al., 2000) is a 
fairly brief measure of neurocognitive feigning requiring examinees to attend to multiple 
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pages of the letters “b”, “d”, “p” and “q,” as well as other similar but non-letter stimuli, 
of varied sizes and orientations. The examinee is instructed to circle every letter “b” on 
each page as quickly as possible. The various computed scores include time to 
completion, errors of commission, and errors of omission. An overall E-Score is 
calculated via an equation incorporating all of the above variables. Errors of commission 
with the letter “d” appear to be a common malingering strategy, and Boone et al. (2000) 
found that a criterion of more than three commission errors resulted in 77% sensitivity 
and 100% specificity among traumatic brain injury and learning disability patients. In 
their study of malingered ADHD, Jasinski, Harp, et al. (2011) found that the b test E-
Score was useful in identifying feigners, especially when used in combination with 
symptom validity tests. 
 Computerized Test of Information Processing (CTIP). The CTIP (Tombaugh & 
Rees, 2000) is one of many Continuous Performance Tasks (CPTs) currently increasing 
in frequency of use in neuropsychological evaluations. The CTIP is purported to assess 
speed of information processing and reaction time. The CTIP is comprised of three 
subtests: Simple Reaction Time (RT), Choice RT, and Semantic Search RT. The first 
measures simple reaction time to a specified letter on the computer screen, the second 
requires different responses depending on which of two words appears on the screen, and 
the third requires the individual to press a key to indicate if a word presented is part of a 
specified semantic category. Because these subtests range from relatively easy to more 
difficult, progressively longer reaction times are expected for individuals attempting to 
malinger attention deficits. The primary variable of concern is the Median Reaction Time 
variable for each trial (Tombaugh & Rees, 2000).   
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 The majority of research with the CTIP has been conducted within a traumatic 
brain injury population (e.g. Willison & Tombaugh, 2006), and the norms are based 
solely on patients with traumatic brain injury. However, the study by Jasinski, Harp, et al. 
(2011) examined the CTIP in detection of malingered ADHD and showed that several 
variables on the CTIP, including the simple, choice, and semantic median reaction times 
as well as the simple and choice reaction time coefficient of variation may be useful in 
detecting feigned ADHD symptoms, with effect sizes ranging from d = 0.82 to d = 1.01.  
Additionally, the semantic choice reaction time exhibited moderate sensitivity to 
malingering at 68.2% (Jasinski, Harp, et al., 2011).  
 Wechsler Adult Intelligence Scale-IV (WAIS-IV): Digit Span (DS), Coding (C), 
and Symbol Search (SS) subtests. The WAIS-IV (Wechsler, 2008) is a test system 
measuring general intellectual functioning, comprised of index scores in verbal 
comprehension, perceptual reasoning, working memory, and processing speed. The 
present study included the following subtests: Digit Span [DS] (forward, backward, 
sequencing, and Reliable Digit Span), Coding [C], and Symbol Search [SS]. The Digit 
Span subtest requires participants to repeat increasing strings of digits according to the 
given instructions. The Digit Span subtest has been studied extensively in traumatic brain 
injury populations, and it has demonstrated adequate sensitivity (60%), strong specificity 
(87%) and large effect sizes (d = 1.08). Reliable Digit Span has demonstrated similar 
sensitivity (63%), specificity (86%), and effect sizes (d = 1.34) for detecting malingering 
(Jasinski, Berry, Shandera, & Clark, 2011). 
 The Coding and Symbol Search subtests comprise the Processing Speed Index, 
and they measure visual-motor coordination and speed of mental processing by asking 
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participants to transcribe symbols according to a given code or to determine whether a set 
of symbols contains a target symbol, respectively (Wechsler, 2008). These subtests were 
selected based on the rationale that students attempting to feign ADHD might slow their 
performance in order to demonstrate difficulty attending to stimuli (Marshall, et al., 
2010). In Jasinski, Harp, et al. (2011), the Processing Speed Index of the WAIS-IV was 
selected by a statistical package as the best single predictor of feigned ADHD.  
 Woodcock-Johnson-III Test of Achievement (WJ-III): Reading Fluency (RF) Subtest. 
The Woodcock-Johnson-III Test of Achievement (Mather & Woodcock, 2001) is a system used 
to measure achievement in specific areas such as arithmetic, reading, and written expression. The 
Reading Fluency subtest requires participants to read short sentences as quickly as possible and 
circle “yes” or “no” to indicate the accuracy of the statements. There is a three-minute time limit 
on the task, and therefore, it operates as a test of both reading comprehension and processing 
speed. Grade-Equivalent (G-E) and Age-Equivalent (A-E) scaled scores are calculated from the 
total correct. Jasinski, Harp, et al. (2011) found that the A-E variable of the WJ-III Reading 
Fluency demonstrated moderately high sensitivity to malingered ADHD (68.2%)  and good 
specificity to true ADHD (95%). 
Post-test measures. 
 Post-test materials included debriefing forms for both the honest and malingering 
groups elaborating on the nature of the study (see Appendices M and N).  A post-test 
questionnaire was also incorporated and required participants to reiterate their 
instructions and indicate how well they understood them, to what degree they were able 
to follow them, and the amount of effort put forth during testing (see Appendix L). The 
scale ranged from 1 to 5 with a response of 1 (“Not at All”) indicating that the participant 
did not understand instructions, perceive his or herself as successful, or put forth effort, 
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and a response of 5 indicating the most understanding, success, effort, etc. Permission 
forms for data usage and contact for future research were also employed (see Appendices 
O and P). Finally, payment receipts were utilized for individuals in the NLM group and 
for individuals in the clinical group who received monetary compensation instead of 
research credits for their participation (see Appendices Q and R).  
Procedures 
 The participants were primarily recruited from the psychology subject pool/mass 
screening session, based on their responses to the screening measure. Potential 
participants were then contacted by telephone by either the principal investigator or a 
research assistant. Phone interviews were conducted to ascertain whether or not an 
individual met the inclusion criteria for the study. Individuals who met the inclusion 
criteria for the groups were asked to participate in the study, and individuals who did not 
meet criteria were thanked for their time. Participants in the ADHD-H, ADHD-LD, and 
ADHD-ANX groups were asked to abstain from stimulant medication use for 12 hours 
prior to testing. Participants received a reminder email and reminder phone call 
approximately 24 hours before their scheduled testing time.  
 The nine individuals randomly assigned to the NLH group received five of their 
six required research credits for completion of the test battery. Participants who were 
randomly assigned to the NLM group were compensated with five research credits and an 
additional $25 dollars upon completion of the test battery. The monetary incentive was 
initially presented to participants as a conditional reward for successfully faking ADHD 
on the test measures; however, all participants in the NLM group received this 
compensation. Participants recruited for the ADHD-H, ADHD-LD, and ADHD-ANX 
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groups were also compensated with five research credits upon completion of the test 
battery. If clinical participants were not in need of research credits, they were 
compensated with $40 for their participation. No participants elected not to complete the 
test battery. 
 Testing was conducted on an individual basis and typically lasted between two 
and a half and three and a half hours, with few exceptions. There were two researchers 
present on the day of the assessment. The first researcher (RA1) conducted the pre- and 
post-test sessions, and the second researcher (RA2) administered the test battery in 
counter-balanced order. This ensured that RA2 was blind to the participant’s assigned 
experimental condition while the test battery was being administered. At the time of the 
assessment, RA1 greeted the participants, obtained the informed consent, and gave a 
short demographic questionnaire (see Appendix G). At this time, the researcher 
confirmed that individuals in the ADHD-H and ADHD-CO groups did, in fact, abstain 
from stimulant medication use for the 12 hours prior to testing. The participants were 
then administered the ASRS, the BDI and the BAI to gauge current symptoms. The 
WRAT was also administered during the pre-test session to provide information about 
specific deficits in writing or reading ability. These measures were incorporated into the 
pre-test session to ensure that individuals responded honestly and not under feigning 
instructions and also to enable the researchers to evaluate between group differences.  
 The participants were given a brief description of the study before being presented 
with their instructions. RA1 explained the instructions to the participants. NLH, ADHD-
H, ADHD-LD, and ADHD-ANX participants received instructions to complete the test 
battery honestly and give their best effort (see Appendix H). Participants assigned to the 
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NLM group were first provided with a handout describing a scenario where they would 
be externally rewarded for faking ADHD well enough to receive a diagnosis (see 
Appendix I). They were then given a packet of information about ADHD which included 
a description of the disorder and its symptoms as well as example screening questions 
(see Appendix J). Participants were permitted up to five minutes to study the packet. 
After the participants indicated that they felt adequately familiar and comfortable with the 
information and RA1 answered any questions about the instructions, the researcher 
administered an instruction check questionnaire requiring the participants to reiterate 
their instructions, write down a few symptoms of ADHD, and describe their strategies for 
faking ADHD (see Appendix K). The participants were then reminded to complete the 
test battery as if they were operating under the given scenario, and RA2 entered the room 
in place of RA1 and administer the test battery in counter-balanced order.  
 Given the length of the battery, participants were allowed breaks as needed. Once 
testing was completed, RA1 returned to the testing room while RA2 exited. RA1 then 
gave participants the post-test questionnaire (see Appendix L). The questionnaire asked 
participants to write down the instructions they were given at the beginning of the 
assessment and indicate the degree to which they understood the instructions, the 
perceived difficulty of following the role, the extent to which they felt able to respond 
appropriately under the given instructions, the amount of effort they exerted for the test 
battery, and the extent to which the monetary compensation was motivating to fake well. 
Finally, participants were debriefed about the purpose of the study and the deception 
concerning the monetary incentive. Participants were compensated accordingly for their 
time, instructed not to discuss the study with others, and thanked for their participation. 
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Chapter 3: Results 
Sample Description 
 Demographic data. 
 A total of 88 participants, 74 from the University of Kentucky PSY 100 subject 
pool and 14 recruited by flier, entered the study. Data from twelve participants were 
excluded from analysis for various reasons, as detailed next. Two individuals were 
dropped because they endorsed reasons for exclusion on their demographics 
questionnaires which were not given during the telephone screening: a diagnosis of 
Central Auditory Processing Disorder and a history of head injury, respectively. Four 
additional participants were not included because they endorsed a history of depression. 
Three individuals were removed because they were outliers on either the age or WRAT 
Word Reading standard score variable. One individual was excluded because he could 
not maintain wakefulness during the testing, and another individual’s data were dropped 
because the testing session was terminated due to inclement weather. Finally, one 
individual was excluded because he indicated on the post-test questionnaire that he did 
not give adequate effort in following instructions. The effort question on the post-test 
questionnaire was phrased “How hard did you try?” and the scale ranged from 1 “Not at 
All” to 5 “Your Hardest” (see Appendix L). Any response below 4 was considered 
inadequate effort and the participant was dropped from final analysis. Overall, six 
participants from the NLM group, five participants from the ADHD-H group, and one 
participant from the NLH group were excluded from analyses, resulting in the following 
sample sizes: NLH n=9, NLM n=23, ADHD-H n=22, and ADHD-CO n=22. Of the 
original participants, 76 produced data that were considered valid for analysis. 
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 In the final sample, 44 participants had been diagnosed with ADHD, and 32 had 
not been. The overall sample was 45.7% male. On average, the sample participants were 
19.5 years old (SD = 1.44) and had completed 12.9 years of education (SD = 1.10). Only 
3.4% of individuals had repeated a grade, and participants had an average Wide Range 
Achievement Test (WRAT-IV) Word Reading subtest standard score of 100.8 (SD = 
11.49). The sample was 93.9% right-handed, and the racial/ethnic makeup of the sample 
was overwhelmingly White (96.7%), with slight representation of other ethnicities (2.2% 
Black and <1% Hispanic). Table 3.1 presents the demographic makeup of the sample by 
assigned group. There were no statistically significant differences between groups on 
these variables.  
 Diagnostic data. 
Participants with ADHD received their diagnoses at an average age of 11.6 years 
(SD = 3.81). ADHD subtype was unspecified for 40.9% of the participants. Of the 
remaining participants, 34.1% were diagnosed with ADHD-Combined subtype, 15.9% 
were diagnosed with ADHD-Predominantly Inattentive subtype, and 9.1% were 
diagnosed with ADHD-Predominantly Hyperactive subtype. Approximately 15.9% of 
participants with ADHD could not recall which type of diagnostic professional gave them 
their diagnoses. Of the remaining individuals with ADHD, 43.2% reported that they 
received their diagnosis from a psychologist, 31.8% reported that they received their 
diagnosis from a psychiatrist, and 9.1% reported that they received their diagnosis from a 
family physician. There was a significant difference between the two clinical groups on 
type of diagnostic professional (χ2 = 4.12, p = .043), such that significantly more 
individuals in the ADHD-H group received their diagnoses from family physicians than 
 
36 
did the individuals in the ADHD-CO group. Of the individuals with ADHD, only 18.2% 
were not currently being medicated. Overall, 45.5% of participants with ADHD were 
prescribed an amphetamine drug (29.6% Adderall and 15.9% Vyvanse), 18.2% were 
prescribed a stimulant in the methylphenidate family (13.6% Concerta, 4.6% Focalin, 
0.0% Ritalin), 2.3% were prescribed the non-stimulant Strattera, 9.1% of participants 
reported being treated with a combination of the above medications, and 6.8% of 
participants reported that they were treated with a medication other than those listed 
above. Nearly half of all participants with ADHD were receiving accommodations from 
the university (43.2%), and significantly more individuals in the ADHD-CO group were 
receiving accommodations than in the ADHD-H group (χ2 = 5.40, p = .020). Of the 
participants with ADHD-CO, 59.1% of participants reported a history of diagnosed 
anxiety disorder, and 40.1% of participants reported a history of diagnosed learning 
disorder. No individuals in the ADHD-H group endorsed a history of comorbid anxiety or 
learning disorder, and this resulted in a statistically significant difference on diagnosis of 
anxiety (χ2 = 18.03, p = .000) and diagnosis of learning disorder (χ2 = 11.06, p = .000). 
Table 3.2 presents the ADHD-related diagnostic characteristics of participants with 
ADHD and those with a comorbid diagnosis. Participants in the ADHD-CO group 
differed significantly from the ADHD-H group on type of diagnostic professional, 
whether or not they were receiving accommodations, and their comorbid diagnoses of 
anxiety or learning disorder.  
The Adult ADHD Self-Report Scale (ASRS) Parts A and B, screening measures 
for ADHD symptomatology, were given under standard instructions prior to experimental 
manipulation. These variables exhibited some skewness, kurtosis, and heterogeneity in 
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variance, and therefore, non-parametric Kruskal-Wallis statistics were used. Main effects 
were found for ADHD diagnosis on the ASRS measures, with diagnosed participants 
endorsing higher levels of ADHD symptoms than the nonclinical participants on both 
ASRS Part A (K = 29.92, p = .000) and ASRS Part B (K = 37.96, p = .000). Participants 
with a diagnosis of ADHD were compared to those with no diagnosis of ADHD. On Part 
A of the ASRS, NLH participants had an average raw score of 8.90 (SD = 3.91), and 
NLM participants averaged 9.69 (SD = 3.41). The clinical groups average much higher 
raw scores with a mean of 14.52 (SD = 2.83) for the ADHD-H group and 14.77 (SD = 
2.99) for the ADHD-CO group. Similar distributions were apparent on the ASRS B, with 
the following means and standard deviations by group: NLH (M = 14.70, SD = 7.20), 
NLM (M = 15.62, SD = 5.55), ADHD-H (M = 26.48, SD = 7.68), and ADHD-CO (M = 
28.64, SD = 5.44). These findings support the diagnostic integrity and credibility of the 
experimental groups.  
Group Differences on Test Measures 
 Self-Reported ADHD Symptoms.  
 The 76 participants completed the Barkley Adult ADHD Rating Scale (BAARS-
IV) under instruction (i.e. either honest or malingering instruction) to provide information 
about how individuals assigned to feign ADHD tend to self-report ADHD symptoms. 
The Inattention, Hyperactivity, Impulsivity, Total ADHD, and Sluggish Cognitive Tempo 
raw score indices and associated Symptom Counts discussed previously were examined, 
and Table 3.3 presents the group results on these variables. 
 Kruskal-Wallis non-parametric analyses revealed statistically significant (p < .01) 
differences on each of the nine variables from the BAARS-IV. Follow-up Mann-Whitney 
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U contrasts demonstrated that the NLM group endorsed statistically significantly higher 
rates of ADHD symptoms than the NLH group on all nine variables. The NLM group 
also self-reported statistically significantly higher scores on the Hyperactivity index than 
both of the clinical groups: ADHD-H and ADHD-CO.  There were no significant 
differences between the NLM group and either clinical group on the remaining eight 
variables. These findings suggest that the individuals assigned to malinger were able to 
successfully “fake” ADHD on a self-report scale, increasing their self-report of ADHD 
symptoms significantly in proportion to nonclinical individuals responding under honest 
instructions.  
 A further manipulation check was conducted, comparing the NLH and NLM 
groups on several variables which were administered under experimental manipulation. 
As previously discussed, the NLM group endorsed statistically significantly more ADHD 
symptoms across all domains of the BAARS-IV than did the NLH group (see Table 3.3). 
Additionally, the NLM group performed statistically significantly (p < .01) worse than 
the NLH group on six of the seven variables from dedicated effort tests which were 
examined. The exception was a statistically non-significant difference between the two 
groups on the b Test E-Score variable. The results of these comparisons are presented in 
Table 3.4.  
 Effort Test Performance. 
As noted earlier, participants completed a number of tests under instruction, 
including some embedded processing speed indices from achievement and intelligence 
measures in addition to the dedicated effort tests. Though dedicated Symptom Validity 
Tests (SVTs) are very useful for detecting malingering in clinical settings, research is 
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being directed at developing or establishing useful embedded measures for which a 
malingered performance is typically more difficult to coach.  
Though a few tests were normally distributed, many measures violated the 
assumptions of normality; therefore, only non-parametric results are presented to 
preserve comparability of reported statistics. Performance on these measures was 
analyzed with a series of omnibus tests using Kruskal-Wallis one-way ANOVA. Table 
3.5 presents the test data by group as well as the results of these omnibus tests.  
Statistically significant group differences were found on all measures, with the 
exception of the WAIS-IV Reliable Digit Span (RDS) variable. For each variable that 
exhibited omnibus group differences, non-parametric follow-up contrasts were performed 
using the Mann-Whitney U test. Table 3.6 displays the detailed results of these contrasts, 
with statistical significance held at p<.01 to reduce the chance of Type I error. 
 In line with hypotheses, statistically significant differences were found between 
nonclinical malingerers and clinical controls with ADHD on the majority of effort 
measures. The NLM group exhibited significantly decreased performances on all 
measures compared to the ADHD-H group. Similarly, the NLM group performed worse 
than the ADHD-CO group on most measures. Exceptions to this include comparable 
performances of the NLM and ADHD-CO groups on the b Test E-Score, the WAIS-IV 
Processing Speed Index (PSI), and the WJ-III Reading Fluency Age-Equivalent (WJ-III 
RF A-E) scale score variables. The ADHD-H and ADHD-CO groups only differed 
statistically significantly on the WJ-III RF A-E scale score, with the ADHD-CO group 
achieving lower scores. This finding suggests that the ADHD-CO group’s WJ-III 
Reading Fluency performance may have been adversely affected by their comorbid 
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diagnoses. The average significant effect size was quite large for both NLM vs. ADHD-H 
(|d| = 1.17) and NLM vs. ADHD-CO (|d| = 0.99).  
Effort Test Utility Indicators 
Test operating characteristics for each effort measure were evaluated by 
determining sensitivity and specificity at a given cutting score. The majority of the effort 
measures examined in this study have established cut scores for use in clinical 
populations. Therefore, the utility of these measures in distinguishing individuals who are 
malingering from those who are giving good effort must be examined in light of the 
specified cut scores. Table 3.7 lists the established cut scores for these measures as well 
as SN, SP, and HR for each. Published cut scores were not available for the CTIP CRT 
Med RT, WAIS-IV PSI, and WJ-III RF A-E variables, and therefore, the high specificity 
optimal cut scores derived in Jasinski, Harp, et al. (2011) were used for the purpose of 
comparison and are noted in Table 3.7.  
The cut scores for the majority of measures demonstrated fair to moderate 
sensitivity (SN ≥.40 and ≤ .70) to malingering instruction, including the TOMM Overall, 
NV-MSVT variables, CTIP Median Reaction Time for all conditions, WAIS-IV PSI, and 
WJ-III RF A-E. Sensitivity was lower (< .40) for trials one and two of the TOMM, the 
LMT, and the b Test E-Score. Sensitivity of the DMT was quite poor (SN < .20).   
  The cut scores demonstrated very high specificity for clinical participants under 
honest instructions, with somewhat higher specificity rates for ADHD-H than ADHD-CO 
(mean change in SP = .043). Exceptions for ADHD-H included the CTIP SCRT Med RT 
and the WAIS-IV PSI for which specificity was moderate (SP > .70). Exceptions for 
ADHD-CO included the b Test E-Score and the CTIP SCRT Med RT, for which 
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specificity was still quite good (SP > .80) and the WAIS-IV PSI and WJ-III RF A-E for 
which specificity was more modest (SP > .50), as presented in Table 3.8.  
The hit rates for classifying malingering (NLM) were computed at a 50% base 
rate. The hit rates for the TOMM Overall variable and all variables of the CTIP were 
moderate (HR[50] > .70) and fair (HR [50] > .60) for trials one and two of the TOMM, 
LMT, b Test E-Score, NV-MSVT variables, WAIS-IV PSI, and WJ-III RF A-E. The 
DMT performed poorly (HR[50] ≤ .60).  
Positive and negative predictive power (PPP and NPP) provide information about 
the ability of a test to predict whether an individual has a specified condition. In other 
words, these values express how well failure (scoring below or above the identified cut 
score) on a test predicts presence or absence of the condition: in this case, instruction to 
malinger. These values were calculated at base rates of 50% and 25% to determine 
classification accuracy for NLM at varying prevalence estimates for the general 
population. Table 3.8 displays PPP and NPP values for the various measures at the 
established cut scores.  
PPP was generally higher than NPP at a base rate of 50%, and many of the 
measures demonstrated excellent PPP (> .90) for malingering, including the TOMM 
variables, DMT, LMT, and CTIP SRT Med RT. PPP for the NV-MSVT variables and the 
CTIP CRT Med RT was also quite high (> .80), and the remaining variables 
demonstrated moderate PPP (.PPP ≥ .60 and ≤ .80). NPP at this base rate was more 
modest with the CTIP CRT Med RT performing the best with NPP > .70. All other 
variables exhibited modest to moderate NPP (NPP ≥.50 and ≤ .70). 
As expected, PPP values were somewhat lower than NPP values at a base rate of 
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25%. The TOMM variables, LMT, DMT, and CTIP SRT Med RT continued to display 
excellent PPP (1.00), and PPP for Criterion A1 of the NV-MSVT and the CTIP CRT 
Med RT remained in the moderately high range (PPP > .70). However, PPP for most of 
the remaining variables was reduced to the modest to moderate range (>.50 and <.70), 
and PPP for the WAIS-IV PSI and the WJ-III RF A-E variables was below chance levels. 
NPP at the 25% base rate was generally higher than PPP and much better than NPP at a 
50% base rate, with all NPP values greater than .70. 
Utility of Effort Tests Used in Combination 
Ideally, clinicians should use more than one effort test during clinical evaluations 
to reduce the chance of false positives, and they should only classify as malingering those 
individuals who demonstrate inadequate effort on multiple measures. Using embedded 
indices in addition to dedicated effort tests is often preferred since the embedded 
measures tend to be less transparent. Therefore, sensitivity, specificity, and hit rate were 
calculated by overall number of tests failed – collapsed across dedicated and embedded 
indices – where failure is defined by the identified cut scores, and these values are listed 
in Table 3.9. When only one failed test was required to be classified as malingering, 
sensitivity to NLM was excellent (SN = .913), specificity was modest to moderate (SP = 
.591) for ADHD-H and modest for ADHD-CO (SP = .409). Requiring two or more 
positive test signs for malingering classification resulted in moderately high sensitivity to 
NLM (SN = .696), and very high to moderate specificity for ADHD-H and ADHD-CO, 
respectively (SP = .955 and SP = .773). Specificity to ADHD-H is perfect (SP = 1.00) 
when three or more positive test signs are required, but five or more positive test signs 
are required to achieve perfect specificity for ADHD-CO. The maximal overall hit rate 
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for classifying malingering (HR[50] = .773) was obtained when failure on at least two 
tests was required. 
This analysis was conducted a second time, taking into consideration only 
dedicated effort tests, which generally have stronger classification properties. In other 
words, the intelligence and achievement measures (WAIS-IV and WJ-III) were not 
included. The results of this second analysis are reported in Table 3.10. Classifying those 
who failed one or more tests as malingering resulted in high sensitivity to malingering 
(SN = .870), as well as high specificity for ADHD-H (SP = .909) and ADHD-CO (SP = 
.864). This criterion also achieved the highest maximal hit rate for classifying 
malingering (HR[50] = .761). Perfect specificity for ADHD-H and ADHD-CO was 
achieved at a cut score of two or more tests for the former and three or more tests for the 
latter. These results raise the possibility of decreased specificity for ADHD with a 
comorbid disorder diagnosis.  
To identify the most powerful combination of effort tests, a binomial logistic 
regression was performed (N = 76), where test performance was utilized to predict honest 
vs. malingering instruction. The variables included the TOMM Overall, LMT, DMT, b 
Test E-Score, NV-MSVT Overall, WAIS-IV PSI, and WJ-III A-E, and the tests selected 
as predictors in the regression model were determined by a forward conditional stepwise 
method. The results of the analysis are displayed in Table 3.11. The TOMM Overall 
variable was selected for Step 1 of the stepwise regression as the best single predictor. In 
the second step, the TOMM Overall variable was added to the LMT, resulting in 
significant change in the likelihood ratio (Δ-2LL), or in other words, significant 
improvement in overall model fit. The NV-MSVT Overall variable was added in the third 
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step, resulting in further incremental power. However, the NV-MSVT did not improve 
the overall classification accuracy, though it may be more robust in a larger sample. The 
addition of other tests did not significantly improve the model fit, and therefore, only 
three steps were entered. 
Additional Analyses 
 Nonparametric follow-up analyses were performed to explore potential 
differences between the two original comorbid groups – ADHD-LD (n = 9) and ADHD-
ANX (n = 13) – on neurocognitive feigning measures. These analyses revealed no 
statistically significant differences between the two subgroups on the aforementioned 
variables. However, the analyses were likely underpowered due to the small sample sizes 
in these groups.  
 Additional nonparametric analyses were conducted to compare the participants in 
the ADHD-H group who received their diagnoses prior to age 13 to those individuals 
who received their diagnoses at or after the age of 13. The purpose of these analyses was 
to reveal possible differences between individuals who received the diagnosis of ADHD 
at a younger age and individuals who were older at the time of diagnoses. However, there 
were no statistically significant differences between the two subsamples on the test 
variables.  
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Table 3.1  
Demographic Characteristics of Participants Included in Final Analyses 
 Group Descriptives                                  Omnibus Test 
 NLH NLM ADHD-H ADHD-CO  F or χ2\  
  n = 9 n = 23 n = 22 n = 22  N = 76 P 
Male % 44.44 56.52 50.00 31.82  2.96 .398 
         
Age M 19.44 20.04 19.05 19.50  1.89 .193 
 SD 1.59 1.33 1.29 1.54    
         
Education Yr. M 12.67 13.26 12.73 13.09  1.16 .332 
 SD 1.00 0.92 1.12 1.34    
         
Repeat Grade % 0.00 4.35 0.00 9.09  2.82 .420 
         
WRAT:  M 99.44 106.04 98.55 99.32  2.19 .097 
WR St.S SD 16.08 8.21 8.18 13.47    
         
Right-handed % 88.89 95.65 95.45 95.45  0.70 .873 
         
Ethnicity       7.20 .303 
White % 100.00 86.96 100.00 100.00    
Black % 0.00 8.70 0.00 0.00    
Hispanic % 0.00 4.35 0.00 0.00    
Other % 0.00 0.00 0.00 0.00    
 
Note.  NLH = Normal Honest; NLM = Normal Malingering; ADHD-H = ADHD Honest; 
ADHD-CO = Comorbid ADHD; M = Mean; SD = Standard Deviation; WRAT: WR St.S 
= Wide Range Achievement Test-IV (WRAT-IV) Word Reading Standard Score.  
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Table 3.2 
ADHD Diagnostic Characteristics of Participants in Final Analyses 
 Group Descriptives  Omnibus Test 
 ADHD-H ADHD-CO  t or χ2  
  n = 22 n = 22  n = 44 P 
Dx. Age M 11.59 11.55  .040 .969 
 SD 3.67 3.95  - - 
       
ADHD Type     2.07 .150 
Inattentive % 9.10 22.70  - - 
Hyperactive % 4.50 13.60  - - 
Combined % 31.80 36.40  - - 
Unspecified % 54.50 27.20  - - 
       
Dx. Prof.     4.12 .043* 
Psychologist % 31.80 54.50  - - 
Psychiatrist % 22.70 40.90  - - 
Fam. Phys. % 18.20 0.00  - - 
Unspecified % 27.20 4.50  - - 
       
ADHD Med     .028 .867 
       
Adderall % 31.80 27.30  - - 
Vyvanse % 9.10 22.70  - - 
Concerta % 13.60 13.60  - - 
Focalin % 9.10 0.00  - - 
Ritalin % 0.00 0.00  - - 
Strattera % 0.00 4.50  - - 
Combination % 9.10 9.10  - - 
Other % 9.00 4.50  - - 
None % 18.20 18.20  - - 
       
Accommodations % 27.3 59.10  5.40 .020* 
       
Comorbid Dx.       
Anxiety % 0.00 59.10  18.03 .000** 
Learning Disorder % 0.00 40.90  11.06 .001** 
 
Note. ADHD-H = ADHD Honest; ADHD-CO = Comorbid ADHD; M = Mean, SD = 
Standard Deviation; Dx. Age= age of ADHD diagnosis; Dx. Prof.= type of diagnostic 
professional; Fam. Phys.= Family Physician; Comorbid Dx. = Presence of second 
diagnosis.  
* = significant at p < .05 level. ** = significant at p < .001 level. 
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Table 3.3 
BAARS-IV: Mean Group Differences  
 Group Descriptives 
 Omnibus Test  
(N = 76) 
 
NLH 
n = 9 
NLM 
n = 23 
ADHD-H 
n = 22 
ADHD-CO 
n = 22 
 
  
 M (SD) M (SD) M (SD) M (SD)  K P 
Inatt. Raw 14.11 (4.28) a 23.39 (4.74) b 21.50 (4.73) b 21.19  (6.23) b  19.13 .000** 
        
Hyp. Raw 7.44 (2.40) a 13.78 (2.75) b 11.05 (3.54) c 11.71 (2.47) bc  21.90 .000** 
        
Imp. Raw 5.67 (1.94) a 10.48 (2.31) b 10.00 (3.92) b 9.29 (3.15) b  15.03 .002* 
        
ADHD 
Raw 
27.22 (7.68) a 46.04 (12.79) b 42.55 (9.51) b 42.19 (9.91) b  18.02 .000** 
        
SCT Raw 16.22 (4.27) a 21.87 (3.58) b 21.95 (4.48) b 23.90 (6.69) b  11.68 .009* 
        
Inatt. S.C. 0.67 (1.32) a 5.30 (2.30)b 3.77 (2.45) b 3.57 (2.91) b  20.37 .000** 
        
Hyp./Imp. 
S.C. 
0.89 (1.36) a 5.17 (2.23) b 3.86 (2.80) b 3.67 (2.11) b  18.15 .000** 
        
ADHD 
S.C. 
1.44 (2.55) a 10.48 (4.28) b 7.64 (4.18) b 7.24 (4.27) b  21.88 .000** 
        
SCT S.C. 1.00 (2.29) a 4.22 (1.81) b 4.23 (1.82) b 4.76 (2.88) b  13.25 .004* 
 
Note. These values reflect the performance of participants under experimental 
manipulation. BAARS-IV = Barkley Adult ADHD Rating Scale-IV; NLH = Normal 
Honest; NLM = Normal Malingering; ADHD-H = ADHD Honest; ADHD-CO = 
Comorbid ADHD; K = Kruskal-Wallis Chi-Square value; M = Mean; SD = Standard 
Deviation; Inatt. Raw = Inattention Raw Score; Hyp. Raw = Hyperactivity Raw Score; 
Imp. Raw = Impulsivity Raw Score; ADHD Raw = Total ADHD Raw Score; SCT Raw = 
Sluggish Cognitive Tempo Raw Score; Inatt. S.C. = Inattention Symptom Count; 
Hyp./Imp. S.C. = Hyperactivity/Impulsivity Symptom Count; ADHD S.C. = Total 
ADHD Symptom Count; SCT S.C. = Sluggish Cognitive Tempo Symptom Count.  
abc Within each row, columns with different letters are statistically significantly (p < .01) 
different from each other using Mann-Whitney U follow up contrasts.  
* = significant at p < .01 level. ** = significant at p < .001 level. 
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Table 3.4 
Manipulation Check: NLM vs. NLH Neurocognitive Test Performance on Dedicated 
Effort Tests  
 Group Descriptives  
 NLH NLM   
 n = 9 n = 23 K  
 M (SD) M (SD) n = 32 P 
TOMM       
T2 % Correct 100.00 (0.00) 89.48 (11.76) 11.48 .001* 
Ret % Correct 99.56 (0.88) 88.96 (11.33) 11.35 .001* 
     
DMT % 100.00 (0.00) 95.28 (6.83) 8.52 .004* 
     
LMT %  100.00 (0.00) 93.05 (8.04) 9.42 .002* 
     
b test     
E-Score 144.12 (179.29) 180.03 (179.27) 0.79 .373 
     
NV-MSVT     
Criterion A1 97.96 (2.67) 90.18 (6.70) 10.62 .001* 
Criterion A2 96.94 (4.01) 85.65 (9.45) 10.61 .001* 
 
Note. These values reflect the performance of participants under experimental 
manipulation. NLH = Normal Honest; NLM = Normal Malingering; M = Mean; SD = 
Standard Deviation; TOMM = Test of Memory Malingering; T2 % Correct =Trial 2 
percent correct; Ret % Correct = Retention Trial percent correct; DMT % = Digit 
Memory Test Total percent correct; LMT % = Letter Memory Test Total percent correct; 
NV-MSVT = Non-Verbal Medical Symptom Validity Test.  
* = significant at p < .01 level.  
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Table 3.5 
Neurocognitive Feigning Test Results by Group on Dedicated and Embedded Effort Tests  
 Group Descriptives  Omnibus Test (N=67) 
 NLM ADHD-H ADHD-CO    
 n=23 n=22 n=22    
 M (SD) M (SD) M (SD)  K P 
TOMM        
T1 % Correct 80.17 (12.04) 94.55 (8.38) 92.27 (7.81)  20.81 .000** 
T2 % Correct 89.48 (11.76) 99.64 (1.00) 99.82 (0.85)  32.02 .000** 
Ret % Correct 88.96 (11.33) 99.45 (1.41) 99.36 (0.95)  30.31 .000** 
        
DMT % 95.28 (6.83) 99.37 (1.90) 99.50 (1.85)  18.82 .000** 
        
LMT % 93.05 (8.04) 98.89 (1.78) 99.30 (1.43)  13.14 .001* 
        
b test        
E-Score 180.03 (179.27) 45.06 (17.98) 84.22 (107.00)  12.53 .002* 
        
NV-MSVT        
Criterion A1 90.18 (6.70) 96.82 (3.20) 96.82 (3.26)  17.10 .000** 
Criterion A2 85.65 (9.45) 95.23 (4.80) 95.51 (4.72)  17.92 .000** 
        
CTIP        
SRT Med RT 0.50 (0.22) 0.30 (0.04) 0.32 (0.05)  17.39 .000** 
CRT Med RT 0.90 (0.28) 0.56 (0.14) 0.60 (0.13)  25.10 .000** 
SCRT Med RT 7.36 (28.92) 0.83 (0.25) 0.90 (0.22)  20.16 .000** 
        
WAIS-IV        
RDS 8.87 (1.42) 9.32 (1.62) 9.27 (1.58)  1.05 .593 
PSI 91.00 (15.48) 106.82 (16.37) 98.23(9.45)  11.09 .004* 
        
WJ III RF        
A-E 15.25 (4.53) 20.42 (3.28) 17.17 (3.84)  14.83 .001* 
 
Note. These values reflect the performance of participants under experimental 
manipulation. Kruskal-Wallis non-parametric test (df = 2) was used due to violations of 
the assumptions of normality. NLM = Normal Malingering; ADHD-H = ADHD Honest; 
ADHD-CO = Comorbid ADHD.  K = Kruskal-Wallis Chi-Square value; M = Mean; SD = 
Standard Deviation;  TOMM = Test of Memory Malingering; T1 % Correct = Trial 1 
percent correct; T2 % Correct =Trial 2 percent correct; Ret % Correct = Retention Trial 
percent correct; DMT % = Digit Memory Test Total percent correct; LMT % = Letter 
Memory Test Total percent correct; NV-MSVT = Non-Verbal Medical Symptom  
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Table 3.5 (continued) 
 
Validity Test; CTIP = Computerized Test of Information Processing; SRT Med RT = 
Simple Reaction Time median reaction time; CRT Med RT = Choice Reaction Time 
median reaction time; SCRT Med RT = Semantic Choice Reaction Time median reaction 
time; WAIS-IV = Wechsler Adult Intelligence Scale – Fourth Edition; RDS = Reliable 
Digit Span; PSI = Processing Speed Index; WJ III RF= Woodcock-Johnson III Tests of 
Achievement Reading Fluency; A-E = Age-Equivalent Scale Score.  
* = significant at p < .01 level. ** = significant at p < .001 level. 
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Table 3.6 
Mann-Whitney U tests for Individual Contrasts on Dedicated and Embedded Effort Tests  
 NLM vs. ADHD-H NLM vs. ADHD-CO ADHD-H vs. ADHD-CO
   U p d U p d  U p D 
TOMM            
T1 % Correct 79.00 .000** -1.41  96.50 .000** -1.21  172.00 .095 0.29 
T2 % Correct 82.00 .000** -1.23  73.00 .000** -1.25  221.00 .323 -0.20 
Ret % Correct 61.00 .000** -1.31  68.50 .000** -1.31  212.50 .358 0.08 
            
DMT % 127.00 .001* -0.83  118.50 .000** -0.85  231.50 .655 -0.07 
            
LMT %  143.00 .008* -1.02  122.50 .001** -1.10  209.50 .344 -0.26 
            
b test            
E-Score 92.00 .000** 1.07  148.00 .044 0.66  172.00 .152 -0.52 
            
NV-MSVT            
Criterion A1 96.00 .000** -1.28  98.00 .000** -1.28  239.00 .943 0.00 
Criterion A2 96.00 .000** -1.30  91.00 .000** -1.34  234.00 .850 -0.06 
            
CTIP            
SRT Med RT  88.50 .000** 1.28  104.00 .001* 1.14  221.00 .621 -0.45 
CRT Med RT 60.00 .000** 1.82  73.50 .000** 1.40  188.00 .204 -0.30 
SCRT Med RT 74.00 .000** 0.32  98.50 .000** 0.32  198.00 .301 -.030 
            
WAIS-IV            
PSI 118.00 .002* -1.02  170.00 .059 -0.57  161.00 .056 0.66 
            
WJ III RF            
A-E 96.5 .000** -1.33  181.50 .104 -0.47  133.50 .009* 0.93 
 
Note. Mann-Whitney non-parametric test was used due to violations of the assumptions 
of t-test. NLM = Normal Malingering; ADHD-H = ADHD Honest; ADHD-CO = 
Comorbid ADHD; U = Mann-Whitney U value; M = Mean; SD = Standard Deviation; 
TOMM = Test of Memory Malingering; T1 % Correct = Trial 1 percent correct; T2 % 
Correct = Trial 2 percent correct; Ret % Correct = Retention Trial percent correct; DMT 
% = Digit Memory Test Total percent correct; LMT % = Letter Memory Test Total 
percent correct; NV-MSVT = Non-Verbal Medical Symptom Validity Test; CTIP = 
Computerized Test of Information Processing; SRT Med RT = Simple Reaction Time 
median reaction time; CRT Med RT = Choice Reaction Time median reaction time; 
SCRT Med RT = Semantic Choice Reaction Time median reaction time; WAIS-IV = 
Wechsler Adult Intelligence Scale – Fourth Edition; PSI = Processing Speed Index; WJ 
III RF= Woodcock-Johnson III Tests of Achievement Reading Fluency; A-E = Age-
Equivalent Scale Score.  
* = significant at p < .01 level; ** = significant at p < .001 level. 
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Table 3.7 
Effort Test Operating Characteristics for Dedicated and Embedded Effort Tests  
 SN to NLM SP for ADHD-H
SP for ADHD-
CO 
NLM 
HR(50) 
TOMM     
T2 % .391 1.00 1.00 .696 
Ret % .391 1.00 1.00 .696 
TOMM Overall .522 1.00 1.00 .761 
     
DMT (%TOT < 90) .174 1.00 1.00 .587 
     
LMT % (%TOT < 93) .391 1.00 1.00 .696 
     
b test (E-Score ≥ 120) .364 1.00 .857 .635 
     
NV-MSVT     
Criterion A1 (≤ 90) .435 .955 .955 .689 
Criterion A2 (< 88) .478 .909 .909 .692 
NV-MSVT Overall .478 .909 .909 .692 
     
CTIP     
SRT Med RT (≥ .50) .435 1.00 1.00 .718 
CRT Med RT (> .77) ᵃ .609 .910 .909 .767 
SCRT Med RT (≥ 1.05) .609 .727 .818 .710 
     
WAIS-IV     
PSI (< 97) ᵃ .652 .727 .591 .666 
     
WJ III RF     
A-E (< 16) ᵃ .478 .909 .500 .617 
 
Note. SN = Sensitivity; SP = Specificity; HR = Overall Hit Rate based on estimated BR = 
.50; NLM = Normal Malingering; ADHD-H = ADHD Honest; ADHD-CO = Comorbid 
ADHD;  TOMM = Test of Memory Malingering; T2 =Trial 2; Ret = Retention Trial; 
TOMM Overall = raw score <45 on either or both Trial 2 and Retention Trial; DMT 
%TOT = Digit Memory Test Total percent correct; LMT %TOT = Letter Memory Test 
Total percent correct; NV-MSVT = Non-Verbal Medical Symptom Validity Test; NV-
MSVT Overall = failure on either or both Criterion A1 and Criterion A2; CTIP = 
Computerized Test of Information Processing; SRT Med RT = Simple Reaction Time 
median reaction time; CRT Med RT = Choice Reaction Time median reaction time;  
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Table 3.7 (continued) 
 
SCRT Med RT = Semantic Choice Reaction Time median reaction time; WAIS-IV = 
Wechsler Adult Intelligence Scale – Fourth Edition; PSI = Processing Speed Index; WJ 
III RF= Woodcock-Johnson III Tests of Achievement Reading Fluency; A-E = Age-
Equivalent Scale Score. 
ᵃ = cut score derived from Jasinski, Harp, et al. (2011) high specificity optimal cut scores. 
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Table 3.8 
 
Positive and Negative Predictive Power of Dedicated and Embedded Effort Tests 
 
NLM 
BR = .50  BR = .25 
PPP NPP PPP NPP 
TOMM      
T2 % 1.00 .622  1.00 .831 
Ret % 1.00 .622  1.00 .831 
TOMM Overall 1.00 .676  1.00 .863 
      
DMT (%TOT < 90) 1.00 .547  1.00 .784 
      
LMT % (%TOT < 93) 1.00 .622  1.00 .831 
      
b test (E-Score ≥ 120) .793 .587  .561 .815 
      
NV-MSVT      
Criterion A1 (≤ 90) .884 .625  .718 .834 
Criterion A2 (< 88) .834 .634  .626 .839 
NV-MSVT Overall .834 .634  .626 .839 
      
CTIP      
SRT Med RT (≥ .50) 1.00 .639  1.00 .842 
CRT Med RT (> .77) ᵃ .890 .703  .730 .877 
SCRT Med RT (≥ 1.05) .763 .675  .518 .862 
      
WAIS-IV      
PSI (< 97) ᵃ .706 .661  .404 .854 
      
WJ III RF      
A-E (< 16) ᵃ .661 .591  .394 .813 
 
Note. BR = Base rate of malingering; PPP = Positive Predictive Power; NPP = Negative 
Predictive Power; NLM = Normal Malinger; TOMM = Test of Memory Malingering; T2 
=Trial 2; Ret = Retention Trial; TOMM Overall = raw score <45 on either or both Trial 2 
and Retention Trial; DMT %TOT = Digit Memory Test Total percent correct; LMT 
%TOT = Letter Memory Test Total percent correct; NV-MSVT = Non-Verbal Medical 
Symptom Validity Test; NV-MSVT Overall = failure on either or both Criterion A1 and 
Criterion A2; CTIP = Computerized Test of Information Processing; SRT Med RT = 
Simple Reaction Time median reaction time; CRT Med RT = Choice Reaction Time 
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Table 3.8 (continued) 
 
median reaction time; SCRT Med RT = Semantic Choice Reaction Time median reaction 
time; WAIS-IV = Wechsler Adult Intelligence Scale – Fourth Edition; PSI = Processing 
Speed Index. 
ᵃ = cut score derived from Jasinski, Harp, et al. (2011) high specificity optimal cut scores. 
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Table 3.9  
 
Utility Indicators for Failure of Multiple Dedicated and Embedded Effort Tests 
# Tests 
Positive SN to NLM SP for ADHD-H SP for ADHD-CO 
 
NLM HR(50) 
1 .913 .591 .409 .721 
2 .696 .955 .773 .773 
3 .565 1.00 .909 .754 
4 .435 1.00 .955 .708 
5 .304 1.00 1.00 .652 
6 .261 1.00 1.00 .631 
7 .130 1.00 1.00 .565 
 
Note. Measures included TOMM Overall, LMT total percent correct, DMT total percent 
correct, NV-MSVT Overall, WAIS-IV PSI, b Test E-Score, and WJ III RF Age-
Equivalent Scale Score. # Tests Positive = total number of feigning measures (dedicated 
effort tests and embedded indices) on which the participant was identified as malingering 
using the published cut score or identified high specificity cut score from Jasinski et al. 
(2011). SN = Sensitivity; SP = Specificity; HR(50) = Overall Hit Rate based on estimated 
BR = .50; NLM = Normal Malingering; ADHD = ADHD Honest; ADHD-CO = 
Comorbid ADHD. 
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Table 3.10  
Utility Indicators for Failure of Multiple Dedicated Effort Tests 
# Tests 
Positive SN to NLM SP for ADHD-H SP for ADHD-CO 
 
NLM HR(50) 
1 .870 .909 .864 .761 
2 .478 1.00 .909 .696 
3 .348 1.00 1.00 .674 
4 .174 1.00 1.00 .587 
5 .130 1.00 1.00 .565 
 
Note. Measures included TOMM Overall, LMT total percent correct, DMT total percent 
correct, NV-MSVT Overall, b Test E-Score. # Tests Positive = total number dedicated 
effort tests on which the participant was identified as malingering using the published cut 
score or identified high specificity cut score from Jasinski, Harp, et al. (2011). SN = 
Sensitivity; SP = Specificity; HR(50) = Overall Hit Rate based on estimated BR = .50; 
NLM = Normal Malingering; ADHD = ADHD Honest; ADHD-CO = Comorbid ADHD. 
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Table 3.11 
Binomial Logistic Regression Models of Incremental Validity 
Step  -2LL R² % Class. Δ-2LL P 
1 TOMM Overall 58.73 .516 85.5 42.26 .000** 
       
2 LMT % Correct    12.19 .000** 
 TOMM Overall 47.41 .640 89.5 24.38 .000** 
       
3 LMT % Correct    11.88 .001* 
 TOMM Overall    23.76 .000** 
 NV_MSVT Overall 40.57 .707 89.5 7.32 .007* 
 
Note. Forward Stepwise Conditional Logistic Regression was used due to the exploratory 
nature of the data. -2LL = -2 log likelihood; R2 = Nagelkerke R squared; % Class. = % of 
sample correctly classified; Δ-2LL = Change in -2 log likelihood; TOMM Overall = Test of 
Memory Malingering, Failure on either or both TOMM Trial 2 and TOMM Retention 
Trial; LMT % Correct = Letter Memory Test, Total Percent Correct; NV-MSVT Overall 
= Nonverbal Medical Symptom Validity Test, Failure on either or both Criterion A1 and 
Criterion A2.  
* = significant at p < .01 level. ** = significant at p < .001 level. 
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Chapter 4: Discussion 
Overview of Findings 
 The growing prevalence of malingered ADHD on college campuses demonstrates 
the importance of identifying effective instruments to use in ADHD evaluations to 
prevent misdiagnosis. Most of the research in this area has been conducted within the last 
decade, and the trends indicate that many of the dedicated effort tests which have been 
validated for use in traumatic brain injury populations are also effective in the context of 
ADHD. Additionally, research is exploring the possibility of using embedded indices in 
various frequently administered tests, in hopes that these may demonstrate high 
classification accuracy for malingering while avoiding the extra time for effort test 
administration. The present study sought to cross-validate the findings of Jasinski, Harp, 
et al. (2011), which consistent with earlier studies (e.g. Sollman, Ranseen, & Berry, 
2010) indicated that a wide array of measures, ranging from well-established SVTs to 
less researched embedded processing speed indices, are useful in the detection of 
malingered ADHD.  
 As expected, the Barkley Adult ADHD Rating Scale (BAARS-IV) was able to 
differentiate clinical participants from nonclinical honest participants, with clinical 
participants endorsing significantly more ADHD symptomatology. The malingering 
participants also endorsed significantly more ADHD symptomatology than the 
nonclinical honest participants, but contrary to the hypothesis, malingerers did not score 
higher than clinical participants on the majority of BAARS-IV indices. The one 
exception is that the malingerers did endorse significantly more hyperactivity symptoms 
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than the ADHD only control group but not significantly more than the comorbid ADHD 
group.   
 In general, the clinical groups performed comparably to honest, nonclinical 
controls on neurocognitive feigning measures. In line with the hypothesis, individuals 
assigned to malinger ADHD performed significantly worse than clinical controls on the 
vast majority of tests given. The measures with the highest effect sizes for differentiating 
malingered ADHD from honest ADHD controls included the TOMM, the NV-MSVT, 
the CTIP CRT Med RT and SRT Med RT, and the WJ-III RF A-E. These same variables 
best differentiated malingered ADHD from comorbid ADHD, with the exception of the 
WJ-III RF A-E and the addition of the LMT.  
 Though effect size is a good indicator for the magnitude of between group 
differences, it is necessary to examine utility indicators at published cut scores for each of 
the measures to determine how well the tests hold up in a clinical setting. The established 
cut scores generally exhibited modest to moderate sensitivity to malingering, with 
specificity to honest ADHD ranging from moderate to high and specificity to comorbid 
ADHD ranging from modest to high. Contrary to the hypothesis, the DMT demonstrated 
the poorest sensitivity to malingering. 
 Evaluating Positive and Negative Predictive Power provides more information 
about the utility of the tests in a clinical setting because of the advantage of incorporating 
base rate information. A base rate of 50% maximizes classification accuracy, and at this 
base rate, the TOMM, DMT, and LMT achieved PPP > .90, with most other measures 
exhibiting PPP in the .70 to .90 range. This means that there is a strong likelihood that 
someone classified as feigning was actually a malingerer. NPP at this base rate was 
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between .50 and .70, indicating moderate likelihood that the individuals who were 
identified as honest were actually giving their best effort. At a 25% base rate, which 
likely more closely approximates base rate of malingering ADHD in the general college 
population, PPP was typically between .50 and 1.00 with the lowest PPP (WJ-III RF A-
E) falling in the .30 range. NPP for all variables fell within the .80 range, with the 
exception of the DMT which fell in the .70 range.  
 Examining incremental validity when failure on multiple tests is required for 
malingering classification indicated that failure on at least two tests produces the highest 
hit rate when both SVTs and embedded indices are examined and at least one test when 
only dedicated SVTs are examined. These conclusions are consistent with the findings of 
Jasinski, Harp, et al. (2011).    The results of the hierarchical logistic regression indicated 
that the dedicated effort tests still achieve the highest classification accuracy. 
Specifically, failure on both the TOMM and the LMT identified 89.5% of the overall 
sample correctly when tests were introduced individually into the model in a forward 
stepwise fashion. This suggests that these tests used in combination are likely to be most 
useful for detecting malingered ADHD in a college setting.  
 This study also sought to expand the current knowledge of the utility of these 
measures for ADHD evaluations by examining their discriminant validity when 
individuals with comorbid ADHD diagnoses are compared to individuals malingering 
ADHD. Generally, the present results indicate that although the dedicated effort tests can 
differentiate malingered and true ADHD and malingered and comorbid ADHD equally 
well, the specificity of the embedded indices (WAIS-IV Processing Speed Index and WJ-
III RF A-E) to comorbid ADHD is less impressive. There was not a statistically 
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significant difference between the malingerers and the individuals with comorbid ADHD 
on the PSI and A-E variables, and the individuals with comorbid ADHD actually 
performed statistically significantly worse than the ADHD only group on the WJ-III RF 
A-E, in line with the hypothesis. Along with this theme, the incremental validity analyses 
for number of tests failed indicated that inadequate effort, as indicated by performance 
below or above the established cut score, on one additional test should be required for the 
comorbid ADHD group when looking at both dedicated SVTs and embedded indices. In 
other words, in order to obtain respectable specificity for comorbid ADHD, failure on 
three tests should be demonstrated prior to classifying someone as malingering. Overall, 
the previous findings were supported, though the results of this study were generally less 
robust, probably due to smaller samples.  
Limitations 
 The simulation design generally displays strong internal validity relative to known 
group designs, but the concern is that this may come at the expense of external validity. 
The internal validity of the present study was bolstered with efforts to ascertain the 
success of malingering instruction by providing monetary incentives, administering 
instruction checks to ensure that the participants understood their roles, and giving post-
test questionnaires to gauge effort and perceived success. As with any simulation design, 
external validity is sacrificed to some degree given that laboratory settings do not 
perfectly approximate that of a clinical evaluation. This study endeavored to control this 
issue to some extent by providing a realistic and age-relevant scenario and monetary 
incentives to participants and also by including a comorbid group. However, it is still not 
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certain whether these incentives are adequate or if these individuals truly mirror or 
resemble real world malingerers.  
 A second issue with the study is that the researcher could only establish the 
credibility of participants’ ADHD diagnoses to a limited extent. Though the researcher 
could not review medical records for the participants, some restrictions were set in place. 
For example, individuals were only recruited to participate in the study if their ADHD 
diagnoses were based on at least a clinical interview and a minimum of one other source 
of information. Past studies have recognized the distinct possibility that some individuals 
in their clinical control groups may have received their ADHD diagnoses through 
exaggeration or fabrication of symptoms. In order to decrease this potential issue, 
participants were only recruited for the clinical groups if they had received their 
diagnoses prior to the age of 18, which is the age most individuals are when they begin 
their college career. Furthermore, more than half of the ADHD-H sample was diagnosed 
by the age of 12 (no statistically significant differences on any variables between those 
who were and those who were not), providing further support for the credibility of the 
diagnoses. Unfortunately, no restrictions could be placed on the diagnoses of the 
comorbid anxiety and learning disorders due to low base rates of comorbidity of these 
specific disorders in this specific college population.  
 Several limitations are apparent with regards to the ADHD-CO group. The group 
is essentially dichotomous given that the initial ADHD-ANX and ADHD-LD groups 
were combined to increase the sample size. Due to probable differences in presentation 
between these two subgroups as well as the very small individual sample sizes, analyses 
for the ADHD-CO group were likely underpowered, and it is not surprising that no 
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differences between the two subgroups were found. Furthermore, the diagnoses within 
each subgroup are also heterogeneous. Additionally, it is uncertain whether the 
performances of individuals in the ADHD-CO group would be comparable to the average 
individual presenting for an ADHD evaluation in a college setting since many individuals 
with diagnosed anxiety disorders were currently receiving treatment for their symptoms, 
and most individuals with diagnosed learning disorders had received these diagnoses at a 
younger age and learned to function within those parameters over time. 
Conclusions 
 In summary, recognition of the prevalence of malingering ADHD in order to 
obtain unfair advantages within the college environment is on the rise. More research is 
acknowledging the importance of detecting malingering in ADHD evaluations to prevent 
unwarranted distribution of medications and allocation of accommodations within an 
academic setting. The present study has added to the field by providing further support in 
cross-validating the findings of previous studies which indicate the utility of multiple 
dedicated and embedded effort tests within the clinical evaluation context. Furthermore, 
this study has illustrated that the presence of a comorbid diagnosis does somewhat reduce 
the specificity of the embedded measures. Clinicians need to be especially sensitive to the 
complexities of the comorbid presentation and weigh their theories against multiple 
sources of data prior to making a final conclusion regarding potential malingering in the 
context of a comorbid ADHD evaluation. A large-scale study spanning multiple college 
campuses would be ideal for obtaining the necessary sample sizes to adequately examine 
the problem of malingering in the context of comorbid ADHD. 
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Appendix A: Mass Screening Form 
 
What is your:                                                         STUDENT ID # __________________ 
 AGE: ________  
 GENDER: ________  
 Year in school:________ 
 
Do you have a diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) or 
Attention Deficit Disorder (ADD)?     
      YES or NO 
If YES, how old were you when you were diagnosed with ADHD or ADD?  ________ 
 
Are you currently prescribed stimulant medication (Adderall, Ritalin, Concerta, Straterra, 
etc.) for ADHD? 
      YES or NO 
 
Have you ever been prescribed stimulant medication (Adderall, Ritalin, Concerta, 
Straterra, etc.) for ADHD? 
      YES or NO 
 
Are you currently receiving academic accommodations (extra test time, financial aid, 
electronic aids) as a result of having ADHD? 
      YES or NO 
 
In school as a child, did you ever receive any special services (tutoring, special classes, 
extra time on tests) as a result of having ADHD? 
     YES or NO 
 
Do you have a close friend or family member with ADHD? 
      YES or NO 
 
 
How many people do you know who have used stimulant medications without a 
prescription (not including yourself)?  
Circle your answer:  None  1 – 2  3 – 4   5 or more 
 
 
How many people do you know who have faked or exaggerated problems to get a 
prescription for stimulant medication (not including yourself)? 
Circle your answer:  None  1 – 2  3 – 4   5 or more 
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Have you ever been evaluated and/or treated for a learning problem (not including 
ADD/ADHD) such as dyslexia, a reading disorder, or a problem with written 
language, for example? 
      YES or NO 
 
Have you ever been diagnosed with a learning problem such as those mentioned above? 
      YES or NO 
 If YES, what diagnosed learning problem do you have? 
 
 
Have you ever received special help or accommodations within the school system 
because of a diagnosed learning problem with reading and/or writing? 
      YES or NO 
 
Have you ever been evaluated and/or treated for anxiety? 
      YES  or NO 
 
Do you have a diagnosed anxiety disorder? 
      YES or NO 
 If YES, what diagnosed anxiety disorder do you have? 
 
 
Are you currently being treated for anxiety? 
      YES or NO  
 If YES, what medications are you taking for anxiety? 
 
 
Are you currently being treated for depression? 
      YES or NO  
 If YES, what medications are you taking for depression? 
 
Do you have a history of: 
Brain injury?    YES or NO 
Hallucinations or delusions?  YES or NO 
Depression?    YES or NO 
 
Have you been diagnosed with any other psychological or psychiatric disorder? 
      YES or NO 
 IF YES, what diagnoses have you received? 
 
67 
Appendix B: Recruitment Flier 
Attention UK Undergraduates!!! 
 
Do you have  
Attention Deficit Disorder? 
(ADD or ADHD) 
 
If so, you can get paid $40  
to participate in a research study being conducted at the 
University of Kentucky.   
 
We would like to see how effective  
various tests are at diagnosing ADHD  
in college students. 
 
please call or text for more information:   
Kim 
 (502) 779-1481  
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Appendix C: General Phone Screening Form 
 
General Phone Screening Form 
 
(if PSY 100 Student) SAY:  My name is __ and I'm calling from the Department of Psychology.   I'm 
contacting you because you completed the psychology online screening and indicated interest in a 
research study for psychology research credits.  I have a 5-credit study.  Do you still need research credits 
at this time? (if Yes):  Great!  I'd like to tell you more about the study, but first I need to get some general 
information to see if you qualify. Only your first name and phone number will be associated with the 
information you provide, if you tell me at the end of this call that you are still interested.  Ok? 
 
(if Non-PSY 100 Student) SAY: My name is __ and I'm calling from the Department of Psychology.   
I'm contacting you because you expressed interest in participating in Kim Williamson’s paid research 
study on ADHD. Is this a good time for you? (if Yes): Great!  I'd like to tell you more about the study, but 
first I need to get some general information to see if you qualify. Only your first name and phone number 
will be associated with the information you provide, if you tell me at the end of this call that you are still 
interested.  Ok? 
 
1.  How old are you?____________________________ 
If younger than 18 or older than 25, stop and thank them for their time.  
 
2.  Are you an undergraduate student?       Yes No 
  
 If Yes: 
 What school do you attend: _________________________________ 
  
 If No: 
 What is your occupation: ___________________________________ 
  
 
3.  What year are you in school? F So Jr Sr Other: (_____ th    semester) 
 
4.  What is your first language?: _________________________ 
 
5.  This is a study about ADHD and other psychological disorders. We have openings for people with and 
without ADHD.  Have you been ever diagnosed with ADHD?    Yes No 
If yes, stop here and switch to ADHD Group phone screening. 
If no, proceed to next question. 
 
 
5. Do you currently have a diagnosis of anxiety disorder (includes all DSM-IV Anxiety Disorders; E.G. 
Generalized Anxiety, Social Phobia, Obssessive Compulsive Disorder, Panic Disorder, etc.)?  
 Yes No          
     
If yes to #5, inquire about specific diagnoses: 
_________________________________________________ 
  
 
6. Do you currently have a diagnosis of a learning disability (includes DSM-IV learning disorders; E.G. 
Writing Disorder [dysgraphia], Reading Disorder [dyslexia])?    Yes No 
 
 
If yes to #6, inquire about specific diagnoses: -
_________________________________________________ 
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7.  Have you been diagnosed with any other psychological or psychiatric disorders (includes Bipolar 
Disorder, Schizophrenia, Personality Disorders, etc.)?   Yes No  
             
If yes to #7, inquire about specific diagnoses: 
__________________________________________________ 
 
8.  Have you been diagnosed with a neurological disorder (includes things like Epilepsy, Tourrettes, 
Central Processing Disorder; If unsure, call or google)?     Yes No 
            
If yes to #8, inquire about specific diagnoses: 
__________________________________________________ 
 
 
*If yes to 6, 7, or 8, EXCLUDE (unless comorbid ADHD; in which case, you would no longer be on this 
form).  
 
 
9. Have you ever had a head injury (including minor concussions)?      Yes No 
            
 If yes, ask the following questions: 
 
 - Have you had a head injury more severe than a concussion?  Yes No 
  If yes, Exclude 
  If they are unsure, ask the following question: 
 
  - Did you lose consciousness?    Yes No 
  If yes:  For how long?_______________  
   
  - Were you hospitalized?      Yes No 
  If yes:  For how long?_______________ 
 
  - Did you have any tests run?    Yes No 
  If yes:  Which and what did they find?_______________________ 
 
 Exclude for LOC >30 min., positive brain imaging findings (indicating complicated mTBI),  
 or extensive hospitalization. 
  
 -How many past concussions have you had? __________________________ 
  
 -When was your most recent concussion? ____________________________ 
 
 Exclude for more than 2 previous concussions or concussion within the last 6 months. 
 
If no to all of the above,…  
 
SAY:  Thank you very much for answering these questions.  Now let me tell you more about the study.  This  
study involves you taking a number of different tests that are used to diagnose ADHD and other 
psychological disorders.  We are interested in whether these tests can discriminate between people with 
ADHD and people without it.  The tests are all pencil /paper, verbal, or computerized.  If you participate, it 
will take about 4 hours of your time and you will be compensated 5 research credits. 
 
Are you still interested in participating?      Yes No 
 
If Yes: Collect contact information   If No: STOP. Thank you for your time.   
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10.  First name:__________________  Phone:_________________  
 
11.  Gender: M F 
 
12. Date/time scheduled:  __________________________ 
 
13. Group assignment: _____________________ 
 
14. Examiners: ________________________ 
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Appendix D: ADHD Phone Screening Form 
 
ADHD Phone Screening Form 
 
After switching from General phone screening:  
 
I'd like to ask you more about the process you went through to get your diagnosis of ADHD. 
 
1.  When were you diagnosed (age/grade/year?)_____________________________________ 
If 18 or older at the time of diagnosis, tell them that we are only collecting data from individuals who 
received their diagnoses before the age of 18. Thank them for their time. 
 
2. What subtype of ADHD is your diagnosis (Inattentive, Hyperactive, Combined, Not Otherwise Specified           
    [NOS]?_________________________________ 
 
3. What sort of health care professional gave you this diagnosis?  ______________________ 
Be sure to figure out whether it was a psychologist, psychiatrist, or just family physician. 
 
4.  Did you take any tests to get your diagnosis?     Yes No 
 (If yes): What sorts of tests 
 __ pencil / paper that asked about your symptoms 
 __ pencil / paper not asking specifically about symptoms 
 __ Computerized 
 __ Tests of other cognitive abilities, thinking, or learning 
 
5.  Did your parent or guardian fill out any questionnaires?    Yes No 
  
6.  Do you remember how long this evaluation took?  (# Appts, # Hours) 
__________________________________ 
 
7.  Was there someone who came into your school classroom to observe you?  Yes  No----  
-Diagnosis must be based on a minimum of self-report and parent-report measures or self-report and 
clinical interview. Self-report only or less is not acceptable. 
-If you are unsure about the credibility of their diagnosis, finish the interview and tell them you will 
call them back for scheduling purposes. Contact me about this.  
 
8. Do you have access to a diagnostic report or evaluation?    Yes No   
 
9.  Are you taking medication for this right now?      Yes No 
 What kind (If yes): ____________________ 
 How long have you been taking it:___________________ 
 
10.  About how often do you skip a dose, either accidentally or on purpose? _________________ 
Make sure you check about whether they take it on the weekends (many people don’t and don’t 
consider this skipping). 
 
11.  Are you receiving accommodations in any of your courses or through the university? Yes  No 
 If so, what types of help are you getting? ________________________________ 
Common accommodations include extra test time (ask how much extra [50%; 100%], teacher’s notes 
and ppts, testing in a private room, priority registration, preferred seating for tests). 
 
12. We also have openings for people with and without a history of anxiety disorder.  Have you been 
diagnosed with anxiety disorder?       Yes No    
 If yes, complete ANX Group phone screening. 
 If no, proceed to next question. 
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13.  We also have openings for people with and without a history of learning disabilities. Have you been 
diagnosed     
       with a learning disability?        Yes
 No 
 If yes, complete LD Group phone screening. 
 If no, proceed to next question. 
 
14.  Have you been diagnosed with any other psychological, psychiatric, or neurological disorders, or had a 
head  
       injury?           Yes
 No   
 If yes, which: _________________________________________________ 
-If yes to #14, get information about specific diagnoses. If their only additional diagnosis is 
depression, get additional information about type of depression diagnosis and current treatment. 
They can still participate. Also, if they have a history of brain injury, do not exclude for less than 3 
past concussions. (see General Phone Screening for more info) 
-If other disorders than those indicated above, tell them we are not collecting data from individuals 
with those specific diagnoses. Thank them for their time.  
  
If no to all of the above,…  
 
SAY:  Thank you for answering these questions.  Now let me tell you more about the study. This is a study 
about the ability of some tests to properly diagnose people who do or do not have ADHD.  The study takes 
about 3 to 3.5 hours and you will be compensated with (5 research credits or $40). This study involves you 
taking a number of different tests that are used to diagnose ADHD.  Some of them you may have taken 
before.  These are all pencil/paper or computerized tests. The study is conducted at Kastle Hall (ask if they 
know where it is and tell them if they don’t).  One requirement of the study is that you not take your 
stimulant medication for 12 hours before your participation, so that we can know how people with 
ADHD do without treatment.  Would you be interested in participating?     Yes No  
 
If Yes: Collect contact information    If No: STOP. Thank you for your time. 
 
Go ahead and schedule if you can.  
 
15.  First name__________________   Phone_____________________ 
 
16.  Gender: M F 
 
17. Date/Time Scheduled: ______________________ 
 
18. Group Assignment: _____________________ 
 
19. Examiners: __________________________ 
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Appendix E: Anxiety Phone Screening Form 
 
ANX Phone Screening Form 
 
After completing ADHD phone screening:  
 
1.  What type of anxiety disorder have you been diagnosed with?  _____________________ 
 
2.  When were you diagnosed (age/grade/year?)_____________________________________ 
 
3. What sort of health care professional gave you this diagnosis?  ______________________ 
 
4.  Now I'd like to ask you about the process you went through to get diagnosed. (Same evaluation or 
different?) 
Did you take any tests?       Yes No 
 (If yes): What sorts of tests 
 __ pencil / paper that asked about your symptoms 
 __ pencil / paper not asking specifically about symptoms 
 __ Computerized 
 __ Tests of other cognitive abilities, thinking, or learning 
 
5.  Did your parent or guardian fill out any questionnaires?    Yes No 
 
6.  Do you remember how long this evaluation took? 
________________________________________________ 
 
7. Do you have access to a diagnostic report or evaluation?    Yes No   
 
8.  Are you taking medication for this right now?      Yes No 
 What kind (If yes): ____________________ 
 How long have you been taking it:___________________ 
 
9.  Have you ever received any type of counseling services?    Yes No 
 If yes, what type: _____________________________ 
 
10.  Are you receiving any type of counseling services at the present time?  Yes No 
 If yes, what type: _____________________________ 
  
11.  Are you still experiencing any symptoms?     Yes  No 
 
12.  Do you also currently have a diagnosis of a learning disability?   Yes No 
 If yes, switch to LD screening form. 
 
13.  Have you been diagnosed with any other psychological, psychiatric, or neurological disorders, or had a 
head injury?             
 Yes No   
 If yes, which: _________________________________________________ 
If yes to #13, get information about specific diagnoses. If their only additional diagnosis is depression, 
get additional information about type of depression diagnosis and current treatment. They can still 
participate. Also, if they have a history of brain injury, do not exclude for less than 3 past 
concussions. (see General Phone Screening for more info) 
 
If other disorders than those indicated above, tell them we are not collecting data from individuals 
with those specific diagnoses. Thank them for their time.  
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If no to all of the above,…  
 
SAY:  Thank you for answering these questions.  Now let me tell you more about the study. This is a study 
about the ability of some tests to properly diagnose people who do or do not have ADHD.  The study takes 
about 3 to 3.5 hours and you will be compensated with (5 research credits or $40). This study involves you 
taking a number of different tests that are used to diagnose ADHD.  Some of them you may have taken 
before.  These are all pencil/paper or computerized tests. The study is conducted at Kastle Hall (ask if they 
know where it is and tell them if they don’t).  One requirement of the study is that you not take your 
stimulant medication for 12 hours before your participation, so that we can know how people with 
ADHD do without treatment.  Would you be interested in participating?     Yes No  
 
If Yes: Collect contact information    If No: STOP. Thank you for your time. 
 
Go ahead and schedule if you can.  
 
14.  First name__________________  Phone_____________________ 
 
15.  Gender: M F 
 
16. Date/Time Scheduled: ______________________ 
 
17. Group Assignment: _____________________ 
 
18. Examiners: __________________________ 
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Appendix F: Learning Disorder Phone Screening Form 
 
LD Phone Screening Form 
 
After completing ADHD phone screening:  
 
1. Have you been diagnosed with a learning disability?     Yes No 
  If Yes, which: _____________________ 
If disorder of writing (dysgraphia) or disorder of reading (dyslexia), proceed to next question.  
  
If the LD is for math only, tell them we are not collecting data from individuals with that type of LD. 
However, don’t exclude for math and reading or writing. Thank them for their time.  
 
2.  When were you diagnosed (age/grade/year?)_____________________________________ 
 
3.  What sort of health care professional gave you this diagnosis?  ______________________ 
 
4.  Now I'd like to ask you about the process you went through to get diagnosed (Same eval or different?). 
Did you take any tests?       Yes No 
 (If yes): What sorts of tests 
 __ pencil / paper that asked about your symptoms 
 __ pencil / paper not asking specifically about symptoms 
 __ Computerized 
 __ Tests of other cognitive abilities, thinking, or learning 
 
5.  Did your parent or guardian fill out any questionnaires?    Yes No 
 
6.  Do you remember how long this evaluation took? 
_______________________________________________ 
  
7.  Was there someone who came into your school classroom to observe you?  Yes  No 
 
8.  Do you have access to a diagnostic report or evaluation?    Yes No   
 
9.  Are you taking medication for this right now?      Yes No 
 What kind (If yes): ____________________ 
 How long have you been taking it:___________________ 
 
10.  About how often do you skip a dose, either accidentally or on purpose? _________________ 
 
11.  Are you receiving accommodations in any of your courses or through the university? Yes  No 
 If so, what types of help are you getting? ________________________________ 
 
12.  Do you also currently have a diagnosis of anxiety?    Yes No 
 If yes, complete LD screening if you haven’t already. 
 
13.  Have you been diagnosed with any other psychological, psychiatric, or neurological disorders, or had a 
head injury?             
 Yes No   
 If yes, which: _________________________________________________ 
If yes to #13, get information about specific diagnoses. If their only additional diagnosis is depression, 
get additional information about type of depression diagnosis and current treatment. They can still 
participate. Also, if they have a history of brain injury, do not exclude for less than 3 past 
concussions. (see General Phone Screening for more info) 
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If other disorders than those indicated above, tell them we are not collecting data from individuals 
with those specific diagnoses. Thank them for their time.  
  
 
If no to all of the above,…  
 
SAY:  Thank you for answering these questions.  Now let me tell you more about the study. This is a study 
about the ability of some tests to properly diagnose people who do or do not have ADHD.  The study takes 
about 3 to 3.5 hours and you will be compensated with (5 research credits or $40). This study involves you 
taking a number of different tests that are used to diagnose ADHD.  Some of them you may have taken 
before.  These are all pencil/paper or computerized tests. The study is conducted at Kastle Hall (ask if they 
know where it is and tell them if they don’t).  One requirement of the study is that you not take your 
stimulant medication for 12 hours before your participation, so that we can know how people with 
ADHD do without treatment.  Would you be interested in participating?      
      Yes No  
 
If Yes: Collect contact information    If No: STOP. Thank you for your time. 
 
Go ahead and schedule if you can.  
 
14.  First name__________________   Phone_____________________ 
 
15.  Gender: M F 
 
16. Date/Time Scheduled: ______________________ 
 
17. Group Assignment: _____________________ 
 
18. Examiners: __________________________ 
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Appendix G: Demographics Questionnaire 
 
Demographics Questionnaire 
 
INSTRUCTIONS:  Please respond to the following as best you can.  You do not need to share your 
responses with the examiner.  Your responses will NOT be associated with your name.  Please put this in 
the envelope and seal it when done. 
 
Gender:   M     F   
 
Age: _______________   
 
Handedness:     R     L  
 
Ethnic background:     
African American  Hispanic/Latino       Native American 
Asian/Pacific Islander           Caucasian            Other______________________ 
 
Education: Freshman      Sophomore     Junior      Senior       Other _________________________ 
 
Please check which apply to you.  If you respond "Yes," please answer the Additional questions below: 
 
1. Color Blindness        N     Y    
 
2. Repeated a Grade   N     Y  
 
3. Knocked Unconscious       N     Y   
 
 (respond for most severe occurrence) 
Length of Time:  Unconscious________      Hospitalized_________ 
 Age of occurrence: _________  Do you remember this happening?_______ 
 
4. Attention Deficit Disorder  N     Y  
 
Type: ___________________________  Age diagnosed:________ 
 What medication do you take for this?__________________________ 
 Have you taken medication for this in the past 12 hours?      Y / N 
 
5. Learning Disability      N     Y  
   
Type: _____________________  Age diagnosed:________ 
 
6. Current Mood, Anxiety, 
    or Thought Disorder 
 
N     Y 
  
(list separately)  
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
Type: ____________________   Age diagnosed:___   Are you currently being treated?  Y / N 
 
7.  Neurological or Neuro-    
     degenerative Disorder 
 
N     Y 
  
(list separately)  
Type: ___________________    Age diagnosed:___    Are you currently being treated?  Y /N 
Type: ___________________    Age diagnosed:___    Are you currently being treated?  Y /N 
    
Thank you!  Please seal this in the envelope provided. 
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Appendix H: Instructions for Honest Group 
 
Instructions for Honest Groups 
 
Today you will complete a series of psychological tests much like a clinician would use 
to test someone for Attention Deficit/Hyperactivity Disorder (ADHD). You should try 
your hardest on these tests and give your very best effort throughout the testing session.  
 
Are you comfortable with these instructions? Do you still wish to participate in the study? 
 
You will now be introduced to the person who will complete testing with you. The 
examiner does not know what instructions you have been given, so please do not give it 
away!   
 
If you have any questions, please take the time to ask them right now. 
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Appendix I: Instructions for Malingering Group 
 
Instructions for NLM group 
Congratulations! You have been selected for a chance to win $25 cash! 
 
Today you will complete a series of psychological tests much like a clinician would use 
to test you for attention deficit/hyperactive disorder (ADHD). Normally, you would be 
asked to try your best on these tests. That is not what we want you to do today. Instead, 
we want you to perform on the tests exactly how you think someone with ADHD would 
perform. That is, you should try to take the tests in such a way that you look like you 
have ADHD. The tests have scales designed to detect people who are faking, so be 
careful not to be too obvious. If you can take the tests in such a way that you are 
classified as having ADHD without the examiner knowing you are faking, you will 
receive $25 cash at the end of testing. It will help if you imagine the following scenario: 
 
You have a friend on campus who has just been diagnosed with ADHD. She is prescribed 
a stimulant drug (like Ritalin or Adderall) that makes her concentrate better and stay 
awake more easily. Studying becomes much easier for her and takes less time. 
Meanwhile, her grades have improved. On top of that, the University gives her extra time 
to complete exams and other assignments because she has ADHD. Because schoolwork is 
easier, she is able to socialize more often. She tells you that all she had to do was take a 
few tests to receive her diagnosis. You feel you could really use some extra time on exams 
and assignments, and it would be great to have some medication to help you study faster, 
so you decide you will try to get a diagnosis, too. You search the internet for information 
on ADHD, and you make an appointment for testing. 
 
The next few pages contain the information you might find in an internet search for 
ADHD. 
 
[After preparation] 
Are you comfortable with these instructions? Do you still wish to participate in the study? 
You will now be introduced to the person who will complete testing with you.   
Please take the following tests as if you are trying to convince someone that you have 
ADHD.  You should respond to the test items in a way that makes clear that you have 
ADHD. The examiner who tests you will not know what instructions you have been 
given, so please do not give it away!   
 
Remember, if you are successful at deceiving the tests without being detected by the 
examiner as faking, you will win $25! If you have any questions, please take the time to 
ask them right now. 
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Appendix J: Internet Information Packet on ADHD 
 
Internet Information on ADHD 
 
The next several pages will provide you with information about ADHD that you can easily access via the 
internet. You will need to read the following information carefully. Feel free to underline or write notes on 
these pages.  At the end of the internet information, you will be asked to jot down a few symptoms or 
characteristics of people with ADHD to help you make sure the tests classify you as having ADHD. 
 
Website 1 
 
Address http://www.daytrana.com/?SOURCE=GOOG&KEYWORD=p 
 
WHAT ARE THE SYMPTOMS OF ADHD? 
 The most common behaviors exhibited by those who have ADHD are inattention, 
hyperactivity, and impulsivity. People with ADHD often have difficulty focusing, are    
easily distracted, have trouble staying still, and frequently are unable to control their 
impulsive behavior.  
 Because everyone shows signs of these behaviors at times, the DSM-IV-TR specifies that  
the behaviors must appear early in life (before age 7) and continue for at least six months. 
 In children, these behaviors must be more frequent or severe than in other children the    
same age. In addition, the behaviors must interfere with at least two areas of a person’s     
life, such as paying attention in school, completing homework, or making friends.  
 ADHD in adults looks much as it does in children, except that much less hyperactivity is 
present. Still, inattention and impulsivity can have a major effect on functioning at work   
and in social relationships.  People often have difficulty focusing, are easily distracted,    
have trouble staying still, and frequently are unable to control their impulsive behavior.  
 
 
 
 
 
 
 
 
 
 
 
 
 
81 
Website 2 
 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Recognizing Adult ADHD 
Fidgeting, interrupting conversations, losing things, forgetting the reason for a trip             
to the grocery store – everyone acts this way once in a while. But a long and persistent   
history of restless, impulsive, or inattentive behavior may be a sign of Adult ADHD.      
This is especially true if these behaviors have existed since childhood and result in 
problems at work, home, and/or in social situations. 
If you think you may have Adult ADHD, here are several questions you may want to       
ask yourself. These are some of the questions that can help doctors and healthcare 
professionals screen for Adult ADHD. 
Ask yourself these questions and think about how long you have experienced these 
symptoms and how often they occur. If these symptoms are interfering with your      
success at home, at work or with friends, you may want to talk with your doctor or 
healthcare professional about a clinical evaluation. 
 Do you have difficulty concentrating or focusing your attention on one thing? 
 Do you often start multiple projects at the same time, but rarely finish them? 
 Do you have trouble with organization? 
 Do you procrastinate on projects that take a lot of attention to detail? 
 Do you have problems remembering appointments or obligations? 
 Do you have trouble staying seated during meetings or other activities? 
 Are you restless or fidgety? 
 Do you often lose or misplace things? 
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On the next two pages are diagnostic screening tests you find.  Please read through the 
questions.  You do not need to complete the tests. 
 
Website 3 
 
Address http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp 
 
Screener Test 
Many adults have been living with Adult Attention-Deficit Disorder (Adult ADHD) and  
don't recognize it. Why? Because its symptoms are often mistaken for a stressful life. If 
you've felt    this type of frustration most of your life, you may have Adult ADHD; a 
condition your doctor   can help diagnose and treat. 
 
Adult Self-Report Scale (ASRS – V1.1) Screener  
      from WHO Composite International Diagnostic Interview 
© World Health Organization 
  
 
 
How often do you have trouble wrapping up the final details of a            
project, once the challenging parts have been done? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you have difficulty getting things in order when  
you have to do a task that requires organization?  
◘   ◘   ◘   ◘    ◘ 
  
How often do you have problems remembering appointments 
or obligations?   
◘   ◘   ◘   ◘    ◘ 
  
When you have a task that requires a lot of thought, how  
often do you avoid or delay getting started? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you fidget or squirm with your hands or  
your feet when you have to sit down for a long time? 
◘   ◘   ◘   ◘    ◘ 
  
How often do you feel overly active and compelled to do things,  
like you were driven by a motor?   ◘   ◘   ◘   ◘    ◘ 
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Website 4 
 
Address http://psychcentral.com/ADHDquiz.htm 
 
Adult ADD/ADHD Test 
Jasper/Goldberg Adult ADHD Screening Quiz 
by Larry Jasper & Ivan Goldberg  
Instructions: The 24 items below refer to how you have behaved and felt DURING MOST OF 
YOUR ADULT LIFE. If you have usually been one way and recently have changed,  your 
responses should reflect HOW YOU HAVE USUALLY BEEN. For each item, indicate  the 
extent to which it is true by checking the appropriate box next to the item.  
 
1. At home, work, or school, I find my mind wandering from tasks that are uninteresting or     
     difficult.  
2. I find it difficult to read written material unless it is very interesting or very easy.  
3. Especially in groups, I find it hard to stay focused on what is being said in conversations.  
4. I have a quick temper... a short fuse.  
5. I am irritable, and get upset by minor annoyances.  
6. I say things without thinking, and later regret having said them.  
7. I make quick decisions without thinking enough about their possible bad results.  
8. My relationships with people are made difficult by my tendency to talk first and think later.  
9. My moods have highs and lows.  
10. I have trouble planning in what order to do a series of tasks or activities.  
11. I easily become upset.  
12. I seem to be thin skinned and many things upset me.  
13. I almost always am on the go.  
14. I am more comfortable when moving than when sitting still.  
15. In conversations, I start to answer questions before the questions have been fully asked.  
16. I usually work on more than one project at a time, and fail to finish many of them.  
17. There is a lot of "static" or "chatter" in my head.  
18. Even when sitting quietly, I am usually moving my hands or feet.  
19. In group activities it is hard for me to wait my turn.  
20. My mind gets so cluttered that it is hard for it to function.  
21. My thoughts bounce around as if my mind is a pinball machine.  
22. My brain feels as if it is a television set with all the channels going at once.  
23. I am unable to stop daydreaming.  
24. I am distressed by the disorganized way my brain works.  
 
 
When you are done reviewing these materials, please use the paper to jot down 
symptoms that will help you remember how to fake on the tests you will be given. Tell the 
examiner when you are done. 
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Appendix K: Instruction Check for Malingering Group 
 
Instruction Check 
 
 
Please write below the instructions you have been given. The researcher will also ask you 
to verbally describe the role you have been asked to fulfill. 
 
 
 
 
 
 
 
 
Please list below several characteristics of individuals with Attention Deficit 
Hyperactivity Disorder: 
 
1. 
 
2. 
 
3. 
 
 
 
 
Please list a few strategies you will use to convince the tests that you have Attention 
Deficit Hyperactivity Disorder: 
 
1. 
 
2. 
 
3. 
 
 
 
 
 
 
If you have any questions at all, please take the time to ask them now! 
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Appendix L: Post-Test Questionnaire 
Post-test Questionnaire 
Please write the instructions (role) you were given at the very beginning of this study:  
 
 
 
How well did you understand these instructions given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at          Somewhat            Perfectly   
All         Understood              Well 
 
 
How hard did you try to follow the instructions or role given at the very beginning? 
___________________________________________________________ 
1  2  3  4  5 
Not at          Somewhat                Your  
All              Hard              Hardest   
        
 
How difficult was it for you to adhere to the instructions and play the role throughout the 
session?  
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat              Very   
All            Difficult           Difficult 
 
 
How successful do you think you were at following those instructions or playing the role? 
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat         Extremely   
All          Successful         Successful 
 
 
How motivating was the incentive offered for successfully playing the role? 
___________________________________________________________ 
1  2  3  4  5 
Not at           Somewhat         Extremely   
All          Motivating         Motivating 
 
What strategies did you use to make sure you followed your instructions? 
 
1. 
 
2. 
 
3. 
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Appendix M: Debriefing Form for Honest Groups 
 
Explanation of Study:  Debriefing Form for Honest Groups 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively some tests discriminate between individuals with and without ADHD, 
as well as other psychological disorders. Such information is important to accurately diagnosing students 
who deserve accommodations and need treatment for the disorder.  
 
In this study, some students were instructed to fake having ADHD, and they will be compared to a 
group of students who have been previously diagnosed with ADHD and also to a group of students who 
have been diagnosed with ADHD and either anxiety or a learning disability. Thus, the independent variable 
is whether a person was instructed to fake or answer honestly. The dependent variable is how well the 
groups will perform on the different tests. We hypothesize that some of the tests will be better able to detect 
who is faking, but we are unsure of which tests will do the best. The tests used in this study are often used 
to detect faking of a brain injury and have also been used to detect faking of ADHD, and now we want to 
see how well they are able to differentiate feigned ADHD from comorbid ADHD/Anxiety and comorbid 
ADHD/LD. 
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we will 
not get the effort and motivation from participants necessary for us to determine if these tests really work!  
This is an important study that can bring the University of Kentucky much recognition if it is run properly, 
so please do not discuss what you did with anyone! 
 
Thank you again for your participation! It would not be possible to continue psychological 
research without your goodwill and cooperation. We hope that you enjoyed this experiment. If you would 
like to learn more about faking of disorders, please feel free to contact the primary investigator or consult 
the references below. We expect to have the results analyzed by next summer, so feel free to contact the 
primary investigator if you are interested in the findings.  
 
 
    Kimberly Williamson 
    111-C Kastle Hall 
    (502) 779-1481 
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Appendix N: Debriefing Form for Malingering Group 
 
Explanation of the Study:  Debriefing Form for Faking Group 
 
Thank you for participating in our study!  As we told you in the beginning, the purpose of this 
study is to determine how effectively some tests discriminate between individuals with true ADHD and 
individuals asked to fake ADHD. Such information is important to accurately diagnosing students who 
deserve accommodations and need treatment for the disorder.  
 
In this study, some students were instructed to fake having ADHD, and they will be compared to a 
group of students who have been previously diagnosed with ADHD and also to a group of students who 
have been diagnosed with ADHD and either anxiety or a learning disability. Thus, the independent variable 
is whether a person was instructed to fake or answer honestly. The dependent variable is how well the 
groups will perform on the different tests. We hypothesize that some of the tests will be better able to detect 
who is faking, but we are unsure of which tests will do the best. The tests used in this study are often used 
to detect faking of a brain injury and have also been used to detect faking of ADHD, and now we want to 
see how well they are able to differentiate feigned ADHD from comorbid ADHD/Anxiety and comorbid 
ADHD/LD. 
 
In order to motivate you to fulfill your role as well as you could, we offered that you would 
receive a "bonus incentive" of $25 if you followed instructions and were successful in your role.  In reality, 
everyone who received this role is given this incentive, regardless of how well they were able to fake 
ADHD. We said it would only be earned if you were successful to make sure you were motivated and tried 
your hardest to follow your instructions.   
 
We ask that you do not discuss this with anyone.  If others know how the study is run, then we will 
not get the effort and motivation from participants necessary for us to determine if these tests really work!  
This is an important study that can bring the University of Kentucky much recognition if it is run properly, 
so please do not discuss what you did with anyone! 
 
Thank you again for your participation! It would not be possible to continue psychological 
research without your goodwill and cooperation. We hope that you enjoyed this experiment. If you would 
like to learn more about faking of disorders, please feel free to contact the primary investigator or consult 
the references below. We expect to have the results analyzed by next summer, so feel free to contact the 
primary investigator if you are interested in the findings.  
 
    Kimberly Williamson 
    111-C Kastle Hall 
    (502) 779-1481 
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Appendix O: Permission for Use of Data Form 
 
Permission for Use of Data 
 
 
If you do not wish to have your data included, please tell the examiner now. 
 
I   MAINTAIN CONSENT / WITHDRAW CONSENT  to have my data used in 
this study.                    (circle one) 
 
 
______________________________             
Print Name  Date              
 
______________________________             
Sign Name  
 
 ______________________________ 
Witness   Date 
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Appendix P: Permission to Contact for Future Research 
 
Permission to Contact for Future Research 
 
 
Would you be interested in participating in future studies about Attention Deficit-
Hyperactivity Disorder?      
 
_______Yes  _______ No 
 
 
Would you like to be contacted for future research opportunities in this research area?  
 
_______Yes  _______ No 
 
 
 
 
If so, please list: 
 
Name:________________________________ 
 
Phone #:______________________________ 
 
Email:________________________________ 
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Appendix Q: Payment Receipt for NLM Participants 
Receipt for Payment 
 
I acknowledge that I have received $25 payment for my participation in the study 
“Discriminating Between Malingered and Comorbid Attention Deficit/Hyperactivity 
Disorder in a College Sample.” 
 
Name (Printed): ________________________________ 
Signature: _____________________________________ 
SS#: __________________________________________ 
Date: _________________________________________ 
Witness: _______________________________________ 
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Appendix R: Payment Receipt for Clinical Participants Not in Need of Research Credits  
Receipt for Payment 
 
I acknowledge that I have received $40 payment for my participation in the study 
“Discriminating Between Malingered and Comorbid Attention Deficit/Hyperactivity 
Disorder in a College Sample.” 
 
Name (Printed): ________________________________ 
Signature: _____________________________________ 
SS#: __________________________________________ 
Date: _________________________________________ 
Witness: _______________________________________ 
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